NL154598B - Method for the detection and determination of laagmoleculire compounds and of proteins that can specifically bind these compounds, as well as the test pack. - Google Patents

Method for the detection and determination of laagmoleculire compounds and of proteins that can specifically bind these compounds, as well as the test pack.

Info

Publication number
NL154598B
NL154598B NL7016396A NL7016396A NL154598B NL 154598 B NL154598 B NL 154598B NL 7016396 A NL7016396 A NL 7016396A NL 7016396 A NL7016396 A NL 7016396A NL 154598 B NL154598 B NL 154598B
Authority
NL
Grant status
Application
Patent type
Prior art keywords
compounds
laagmoleculire
proteins
determination
detection
Prior art date
Application number
NL7016396A
Other languages
Dutch (nl)
Other versions
NL7016396A (en )
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/964Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/817Steroids or hormones
NL7016396A 1970-11-10 1970-11-10 Method for the detection and determination of laagmoleculire compounds and of proteins that can specifically bind these compounds, as well as the test pack. NL154598B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL7016396A NL154598B (en) 1970-11-10 1970-11-10 Method for the detection and determination of laagmoleculire compounds and of proteins that can specifically bind these compounds, as well as the test pack.

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
NL7016396A NL154598B (en) 1970-11-10 1970-11-10 Method for the detection and determination of laagmoleculire compounds and of proteins that can specifically bind these compounds, as well as the test pack.
ZA7107192A ZA7107192B (en) 1970-11-10 1971-10-27 Process for the demonstration and determination of low molecular compounds and of proteins capable of binding these compounds specifically
AU3508271A AU468060B2 (en) 1970-11-10 1971-10-28
US3850752A US3850752A (en) 1970-11-10 1971-10-29 Process for the demonstration and determination of low molecular compounds and of proteins capable of binding these compounds specifically
FI315571A FI54033C (en) 1970-11-10 1971-11-04 Kombination of reagenser Foer Science paovisande of a bestaemmnade of the components of the reaction mixture of a laogmolekylaer Science foerening a protein Vilket foermaor in that Binda denna of specifically foerening
ES396741A ES396741A1 (en) 1970-11-10 1971-11-06 Process for the demonstration and determination of a component the reaction between a compound of Molecu-lar weight low and a protein capable of binding to this compound.
CH1621671A CH617774A5 (en) 1970-11-10 1971-11-08
DK546271A DK140268C (en) 1970-11-10 1971-11-08
BR745971A BR7107459D0 (en) 1970-11-10 1971-11-09 Process for checking and determination of a component of the reaction between a compound of low molecular weight and a protein capable of joining mind that specifies embalagemde test compound and to perform such a process
DE19712155658 DE2155658C3 (en) 1970-11-10 1971-11-09
CA 127217 CA967464A (en) 1970-11-10 1971-11-09 Process for the demonstration and determination of low molecular compounds and of proteins capable of binding these compounds specifically
GB5196171A GB1348935A (en) 1970-11-10 1971-11-09 Process for the determination of low molecular compounds and of proteins capable of binding these compounds specifically
SE1427871A SE451162B (en) 1970-11-10 1971-11-09 Method for detecting and bestemning of a hapten, testforpackning herfor and method for producing tell up hapten-enzyme conjugate
IT5397071A IT986829B (en) 1970-11-10 1971-11-09 Complex for the execution of essays on protein components
FR7140259A FR2113733A5 (en) 1970-11-10 1971-11-10
BE775187A BE775187A (en) 1970-11-10 1971-11-10 Method for the detection and determination of low-molecular weight compound ones of proteins that are capable of binding specifically these compounds
CA 220820 CA1024918A (en) 1970-11-10 1975-02-26 Coupling product

Publications (2)

Publication Number Publication Date
NL7016396A true NL7016396A (en) 1972-05-15
NL154598B true true NL154598B (en) 1977-09-15

Family

ID=19811504

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7016396A NL154598B (en) 1970-11-10 1970-11-10 Method for the detection and determination of laagmoleculire compounds and of proteins that can specifically bind these compounds, as well as the test pack.

Country Status (10)

Country Link
US (1) US3850752A (en)
BE (1) BE775187A (en)
CA (1) CA967464A (en)
DE (1) DE2155658C3 (en)
DK (1) DK140268C (en)
ES (1) ES396741A1 (en)
FI (1) FI54033C (en)
FR (1) FR2113733A5 (en)
GB (1) GB1348935A (en)
NL (1) NL154598B (en)

Families Citing this family (1023)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630328B2 (en) 1909-07-15 2003-10-07 Genencor International, Inc. Increasing production of proteins in gram-positive microorganisms
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
US3975237A (en) * 1972-11-06 1976-08-17 Syva Company Compounds for enzyme amplification assay - - ecgonine analogs
US3905871A (en) * 1971-05-14 1975-09-16 Syva Co Lactam conjugates to enzymes
US4376825A (en) * 1979-05-07 1983-03-15 Syva Company Enzyme amplification compounds for assays for androgens
US4039385A (en) * 1972-05-08 1977-08-02 Syva Company Cardiac glycoside enzyme conjugates
US4203802A (en) * 1971-05-14 1980-05-20 Syva Company Inhibitable enzyme amplification assay
US4282325A (en) * 1971-05-14 1981-08-04 Syva Company Enzyme bound corticosteroids
US4191613A (en) * 1971-05-14 1980-03-04 Syva Company Malate dehydrogenase conjugates for enzyme immunoassays
US3966556A (en) * 1972-11-06 1976-06-29 Syva Company Compounds for enzyme amplification assay methadone analogs
NL171930C (en) * 1972-05-11 1983-06-01 Akzo Nv Method for the detection and determination of haptens, as well as test packs.
US3790447A (en) * 1972-07-05 1974-02-05 Abbott Lab Streptococci diagnostic method
US4040907A (en) * 1974-06-20 1977-08-09 Syva Company Iodothyronine enzyme conjugates
US4046636A (en) * 1974-06-20 1977-09-06 Syva Company Diazepam enzyme conjugates
US4061466A (en) * 1974-10-16 1977-12-06 Ingvar Gosta Holger Sjoholm Biologically active composition and the use thereof
NL7501215A (en) * 1975-02-01 1976-08-03 Akzo Nv Method for the detection and determination of an antigen or antibody.
US4043872A (en) * 1975-02-20 1977-08-23 Syva Company Polyiodothyronine immunoassay
USRE32696E (en) * 1975-09-04 1988-06-14 Akzona Incorporated Enzymatic immunological method for determination of antigens and antibodies
US4096138A (en) * 1975-12-08 1978-06-20 Scherr George H Immunological test procedure
US4166767A (en) * 1976-03-25 1979-09-04 Dainippon Pharmaceutical Co., Ltd. Insolubilized antibody
JPS5734904B2 (en) * 1976-09-29 1982-07-26
GB1572220A (en) * 1976-10-07 1980-07-30 Mochida Pharm Co Ltd Immunochemical process of measuring physiologically active substances
US4098876A (en) * 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4134792A (en) * 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
US4156081A (en) * 1977-04-15 1979-05-22 Syva Company Theophylline antigens and antibodies
US5605800A (en) * 1978-04-13 1997-02-25 Institut Pasteur Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
FR2422956B1 (en) * 1978-04-13 1980-11-28 Pasteur Institut
DE2825650C3 (en) * 1978-06-12 1981-02-05 Boehringer Mannheim Gmbh, 6800 Mannheim
US4269938A (en) * 1979-03-08 1981-05-26 Eastman Kodak Company Assay of peroxidatively active materials
JPS55152459A (en) * 1979-05-18 1980-11-27 Yamasa Shoyu Co Ltd Method and reagent for measuring quantity of cyclic nucleotide
US4289748A (en) * 1979-05-31 1981-09-15 United States Of America Ultrasensitive enzymatic radioimmunoassay method
US4299916A (en) * 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
US4391904A (en) * 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4347312A (en) * 1980-03-20 1982-08-31 Research Triangle Institute Detection of antibiotics in milk
JPH0115826B2 (en) * 1980-07-01 1989-03-20 Dainippon Pharmaceutical Co
US4323647A (en) * 1980-10-15 1982-04-06 University Of Miami Steric hindrance enzyme immunoassay
US4604365A (en) * 1981-06-02 1986-08-05 Electro-Nucleonics, Inc. Immunoprecipitation assay
WO1982004323A1 (en) * 1981-06-02 1982-12-09 O Neill Sean Immunoprecipitation assay
US5703206A (en) * 1981-09-08 1997-12-30 Univ Rockefeller Macrophage inflammatory protein 2 (MIP-2)
US4419453A (en) * 1981-09-28 1983-12-06 The Dow Chemical Company Immunological agglutination assays with dyed or colored latex and kits
US4506009A (en) * 1982-03-30 1985-03-19 University Of California Heterogeneous immunoassay method
US4535057A (en) * 1982-07-26 1985-08-13 Amf Incorporated Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
US4530900A (en) * 1982-09-13 1985-07-23 Seragen Diagnostics Inc. Soluble insoluble polymers in enzymeimmunoassay
WO1985000605A1 (en) * 1983-07-27 1985-02-14 American Hospital Supply Corporation Process for selective nitrile reduction
FR2550799B1 (en) * 1983-08-17 1986-02-21 Commissariat Energie Atomique Compound labeled with an enzyme, process for its preparation and its use in enzymoimmunologie
DE3433652A1 (en) * 1984-09-13 1986-03-20 Boehringer Mannheim Gmbh Immunochemical measurement method for haptenic and proteins
DE3856224D1 (en) 1988-09-29 1998-08-27 Chiron Corp Detecting a polynucleotide by Ersätzung a chain to a capture probe
US4713347A (en) * 1985-01-14 1987-12-15 Sensor Diagnostics, Inc. Measurement of ligand/anti-ligand interactions using bulk conductance
US4786594A (en) * 1986-05-14 1988-11-22 Syntex (U.S.A.) Inc. Enzyme immunoassay
CA2029006C (en) * 1990-07-27 2001-07-17 Michael R. Detty Dicarboxylic acid oxidation products
CA2031109C (en) * 1990-07-27 1992-01-28 Susan J. Danielson Ligand analogs for immunoassays derived from dicarboxylic acid oxidation products
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US5268298A (en) * 1991-04-26 1993-12-07 Life Technologies, Inc. System for delivering oxygen to a cell culture medium
US5965379A (en) * 1991-07-19 1999-10-12 Cytimmune Sciences Inc. Method for measuring endogenous cytokines
US5464749A (en) 1991-07-22 1995-11-07 Bayer Corporation Immunoassay of free substances in biological fluids
US5939524A (en) * 1991-12-09 1999-08-17 The Scripps Research Institute Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use
US5624804A (en) * 1991-12-20 1997-04-29 The Rockefeller University Immunochemical detection of In vivo advanced glycosylation end products
US5354692A (en) * 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow
US5874423A (en) * 1992-09-10 1999-02-23 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Digitalis-like compounds
US7326535B2 (en) 1993-09-15 2008-02-05 Ortho Diagnostic Systems Inc. Immunoreactive peptides from Epstein-Barr virus
US7060283B1 (en) 1992-09-15 2006-06-13 Ortho Diagnostic Systems, Inc. Immunoreactive peptides from Epstein-Barr virus
US5637467A (en) * 1992-10-13 1997-06-10 Behringwerke Ag Heterogeneous assay using a pendulous drop
US20030152909A1 (en) * 1994-11-16 2003-08-14 Mitrani Eduardo N. In vitro micro-organs, and uses related thereto
US6942862B2 (en) * 1996-04-01 2005-09-13 University Of Washington Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
US5869445A (en) * 1993-03-17 1999-02-09 University Of Washington Methods for eliciting or enhancing reactivity to HER-2/neu protein
US6953573B1 (en) * 1993-03-17 2005-10-11 University Of Washington Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US6562333B1 (en) 1993-06-14 2003-05-13 Schering Corporation Purified mammalian CTLA-8 antigens and related reagents
US6495343B1 (en) 1993-06-18 2002-12-17 The Salk Institute For Biological Studies Cloning and recombinant production of CRF receptor(s)
US6638905B2 (en) * 1993-06-18 2003-10-28 The Salk Institute For Biological Studies Cloning and recombinant production of CFR receptor(s)
US5516639A (en) * 1993-07-22 1996-05-14 Mayo Foundation For Medical Education And Research Antibodies specific for human prostate glandular kallkrein
US20040259113A1 (en) * 1993-07-22 2004-12-23 Mayo Foundation For Medical Education And Research, Hybritech Incorporated Method for detection of metastatic prostate cancer
US6103237A (en) * 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
US5684144A (en) * 1993-07-28 1997-11-04 University Of North Texas Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof
US6884590B1 (en) 1994-02-11 2005-04-26 Cedars-Sinai Medical Center Methods of screening for ulcerative colitis and crohn's disease
US5681699A (en) * 1994-02-11 1997-10-28 Cedars-Sinai Medical Center Methods of diagnosing ulcerative colitis and Crohn's disease
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
EP0804593A1 (en) * 1994-05-10 1997-11-05 Hybritech Incorporated Recombinant hk2 polypeptide
US5589344A (en) * 1994-06-15 1996-12-31 Johnson & Johnson Clinical Diagnostics, Inc. Test kit and method for competitive specific binding assay
DK0705903T3 (en) 1994-08-12 2001-08-27 Myriad Genetics Inc Mutations in the 17q-linked breast and ovariecancerprædisponeringen
DE69519834T3 (en) 1994-08-12 2010-04-01 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services, Rockville A method for detecting predisposition to ovarian and breast cancer
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6048837A (en) * 1994-08-17 2000-04-11 The Rockefeller University OB polypeptides as modulators of body weight
US6124448A (en) * 1994-08-17 2000-09-26 The Rockfeller University Nucleic acid primers and probes for the mammalian OB gene
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6124439A (en) * 1994-08-17 2000-09-26 The Rockefeller University OB polypeptide antibodies and method of making
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US8236493B2 (en) 1994-10-21 2012-08-07 Affymetrix, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US6974666B1 (en) * 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US6531277B2 (en) 1994-10-25 2003-03-11 The Curators Of The University Of Missouri Endometriosis-specific secretory protein
US5843673A (en) * 1994-10-25 1998-12-01 Curators Of The University Of Missouri Method of screening for endometriosis
US5633149A (en) 1994-12-07 1997-05-27 Incyte Pharmaceuticals, Inc. Polynucleotide encoding novel chemokine expressed in inflamed adenoid
US7005509B1 (en) 1995-02-17 2006-02-28 Incyte Corporation Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
US6506553B1 (en) 1995-03-30 2003-01-14 Ortho Diagnostics Systems, Inc. Method for diagnosis of Epstein-Barr virus associated disease
US5777093A (en) * 1995-05-16 1998-07-07 Ramot-University Authority For Applied Research & Industrial Development Ltd. cDNAs associated with ataxia-telangiectasia
US5728807A (en) * 1995-05-16 1998-03-17 Ramot-University Authority For Applied Research And Industrial Development, Ltd. Mutated proteins associated with ataxia-telangiectasia
US5858661A (en) * 1995-05-16 1999-01-12 Ramot-University Authority For Applied Research And Industrial Development Ataxia-telangiectasia gene and its genomic organization
US5837492A (en) 1995-12-18 1998-11-17 Myriad Genetics, Inc. Chromosome 13-linked breast cancer susceptibility gene
US7282327B2 (en) * 1996-01-23 2007-10-16 Affymetrix, Inc. Nucleic acid labeling compounds
US20040210045A1 (en) * 1996-01-23 2004-10-21 Mcgall Glenn Nucleic acid labeling compounds
US7423143B2 (en) * 1996-01-23 2008-09-09 Affymetrix. Inc. Nucleic acid labeling compounds
US6965020B2 (en) 1996-01-23 2005-11-15 Affymetrix, Inc. Nucleic acid labeling compounds
US7291463B2 (en) 1996-01-23 2007-11-06 Affymetrix, Inc. Nucleic acid labeling compounds
US6864059B2 (en) * 1996-01-23 2005-03-08 Affymetrix, Inc. Biotin containing C-glycoside nucleic acid labeling compounds
EP0880598A4 (en) * 1996-01-23 2005-02-23 Affymetrix Inc Nucleic acid analysis techniques
WO1997029212A1 (en) 1996-02-08 1997-08-14 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
EP1728875A3 (en) 1996-02-08 2007-05-09 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
US6924094B1 (en) * 1996-02-08 2005-08-02 Affymetrix, Inc. Chip-based species identification and phenotypic characterization of microorganisms
US5882644A (en) * 1996-03-22 1999-03-16 Protein Design Labs, Inc. Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
JP2000507245A (en) * 1996-03-22 2000-06-13 モアハウス スクール オブ メディシン Immunogenic composition comprising a Porphyromonas gingivalis peptide and methods
US7115722B1 (en) 1997-05-22 2006-10-03 Viventia Biotech, Inc. Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
US6759243B2 (en) 1998-01-20 2004-07-06 Board Of Trustees Of The University Of Illinois High affinity TCR proteins and methods
US20050214827A1 (en) * 1996-07-08 2005-09-29 Burstein Technologies, Inc. Assay device and method
US6331275B1 (en) 1996-07-08 2001-12-18 Burstein Technologies, Inc. Spatially addressable, cleavable reflective signal elements, assay device and method
US20050069923A1 (en) * 1996-07-08 2005-03-31 Mullis Kary Banks Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
US6342349B1 (en) 1996-07-08 2002-01-29 Burstein Technologies, Inc. Optical disk-based assay devices and methods
CA2260361A1 (en) 1996-07-08 1998-01-15 Burstein Laboratories, Inc Cleavable signal element device and method
US20070299005A1 (en) * 1996-09-24 2007-12-27 Tanox, Inc. Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
DE69735375D1 (en) 1996-09-24 2006-04-27 Tanox Inc Gene family of apoptosis-related peptides, peptide encoded thereby and methods for their preparation
US6808880B2 (en) * 1996-10-01 2004-10-26 Geron Corporation Method for detecting polynucleotides encoding telomerase
US7378244B2 (en) * 1997-10-01 2008-05-27 Geron Corporation Telomerase promoters sequences for screening telomerase modulators
US7585622B1 (en) * 1996-10-01 2009-09-08 Geron Corporation Increasing the proliferative capacity of cells using telomerase reverse transcriptase
US6093809A (en) 1996-10-01 2000-07-25 University Technology Corporation Telomerase
US20050013825A1 (en) * 1997-04-18 2005-01-20 Geron Corporation Vaccine containing the catalytic subunit of telomerase for treating cancer
US7262288B1 (en) 1997-04-18 2007-08-28 Geron Corporation Nucleic acids encoding human telomerase reverse transcriptase and related homologs
US6261836B1 (en) 1996-10-01 2001-07-17 Geron Corporation Telomerase
US6610839B1 (en) 1997-08-14 2003-08-26 Geron Corporation Promoter for telomerase reverse transcriptase
US6475789B1 (en) * 1996-10-01 2002-11-05 University Technology Corporation Human telomerase catalytic subunit: diagnostic and therapeutic methods
EP1333094B1 (en) 1996-10-01 2012-04-04 Geron Corporation Human telomerase catalytic subunit
US7622549B2 (en) * 1997-04-18 2009-11-24 Geron Corporation Human telomerase reverse transcriptase polypeptides
US7413864B2 (en) * 1997-04-18 2008-08-19 Geron Corporation Treating cancer using a telomerase vaccine
US6479263B1 (en) 1996-11-14 2002-11-12 Baylor College Of Medicine Method for detection of micrometastatic prostate cancer
DK1114864T4 (en) 1996-12-13 2012-09-03 Schering Corp Mammalian Cell surface antigens and related reagents
US5840322A (en) * 1996-12-19 1998-11-24 Ramot-University Authority For Applied Research & Industrial Devel. Ltd. Anti-oral-microbial adhesion fraction derived from vaccinium
US7687057B2 (en) 1998-01-09 2010-03-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs, and uses related thereto
US6268165B1 (en) 1997-03-19 2001-07-31 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
ES2310006T3 (en) * 1997-04-01 2008-12-16 Theracos, Inc. oral active moiety via momordica charantia, active peptides thereof and their use in the treatment of diabetes.
WO1998050547A3 (en) 1997-05-07 1999-03-11 Schering Corp Human toll-like receptor proteins, related reagents and methods
US5891646A (en) * 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
US7541151B2 (en) 1997-06-05 2009-06-02 Duke University Single-cell biosensor for the measurement of GPCR ligands in a test sample
US6528271B1 (en) * 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
JP2001500391A (en) * 1997-07-11 2001-01-16 ユニバーシティ オブ ノース テキサス Escherichia coli csrB gene, RNA encoded thereby, and method of use
US6762039B2 (en) * 1997-07-15 2004-07-13 Genencor International, Inc. Bacillus subtillis with an inactivated cysteine protease-1
US20030157642A1 (en) * 1997-07-15 2003-08-21 Caldwell Robert M. Increasing production of proteins in gram-positive microorganisms
US6506579B1 (en) 1997-07-15 2003-01-14 Genencor International, Inc. Increasing production of proteins in gram-positive microorganisms using SecG
US6723550B1 (en) 1997-07-15 2004-04-20 Genencor International, Inc. Proteases from gram-positive organisms
US6521421B1 (en) * 1997-07-16 2003-02-18 Genencor International, Inc. Expression vectors encoding Bacillus subtilis disulfide bond isomerase and methods of secreting proteins in gram-positive microorganisms using the same
US6180411B1 (en) 1997-08-01 2001-01-30 The Regents Of The University Of California Light-triggered indicators that memorize analyte concentrations
US7252950B1 (en) 1997-09-04 2007-08-07 The Regents Of The University Of California Assays for detecting modulators of cytoskeletal function
US6300117B1 (en) * 1997-09-15 2001-10-09 Genencor International, Inc. Proteases from gram-positive organisms
US6521440B1 (en) * 1997-09-15 2003-02-18 Genencor International, Inc. Proteases from gram-positive organisms
US6284496B1 (en) 1997-10-03 2001-09-04 University Of South Florida DNA vector for determining the presence of out-of-reading-frame mutations
CA2307345A1 (en) 1997-10-17 1999-04-29 University Of South Florida Method to diagnose and monitor cellular immune deficiencies
US6316241B1 (en) * 1997-11-20 2001-11-13 Genencor International, Inc. Alpha/beta hydrolase-fold enzymes
GB9724629D0 (en) * 1997-11-20 1998-01-21 Genencor Int Bv Alpha/beta hydrolase-fold enzymes
GB9724627D0 (en) 1997-11-20 1998-01-21 Genencor Int Bv Gram positive microorganism formate pathway
US6599731B1 (en) 1997-12-30 2003-07-29 Genencor International, Inc. Proteases from gram positive organisms
US6528255B1 (en) * 1997-12-30 2003-03-04 Genencor International, Inc. Proteases from gram positive organisms
GB9727470D0 (en) * 1997-12-30 1998-02-25 Genencor Int Bv Proteases from gram positive organisms
US6465186B1 (en) * 1997-12-30 2002-10-15 Genecor International, Inc. Proteases from gram positive organisms
US6673914B1 (en) 1998-01-22 2004-01-06 John Wayne Cancer Institute Human tumor-associated gene
US6596501B2 (en) 1998-02-23 2003-07-22 Fred Hutchinson Cancer Research Center Method of diagnosing autoimmune disease
US6060260A (en) * 1998-02-27 2000-05-09 Dade Behring Inc. Methods for reducing adsorption in an assay
WO1999045124A3 (en) 1998-03-04 1999-11-18 Genencor Int Modified forms of pullulanase
US8062908B2 (en) * 1999-03-29 2011-11-22 Orasure Technologies, Inc. Device for collection and assay of oral fluids
ES2264580T3 (en) * 1998-03-30 2007-01-01 Orasure Technologies, Inc. Collection device for analysis in a single step oral fluid.
US6303081B1 (en) * 1998-03-30 2001-10-16 Orasure Technologies, Inc. Device for collection and assay of oral fluids
US6337200B1 (en) * 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
JP2002509706A (en) * 1998-03-31 2002-04-02 ジョン ホプキンズ ユニヴァーシティー Diagnostic and therapeutic methods of lung cancer
US7108968B2 (en) * 1998-04-03 2006-09-19 Affymetrix, Inc. Mycobacterial rpoB sequences
US6699969B1 (en) 1998-04-14 2004-03-02 The Regents Of The University Of California Assays for the detection of microtubule depolymerization inhibitors
US6410687B1 (en) 1998-04-14 2002-06-25 The Regents Of The University Of California Polypeptides for the detection of microtubule depolymerization inhibitors
US6872537B1 (en) 1998-04-14 2005-03-29 Regents Of The University Of California Assays for the detection of microtubule depolymerization inhibitors
US20080206206A1 (en) 1998-05-07 2008-08-28 University Of South Florida Bone marrow-derived neuronal cells
US20020122807A1 (en) * 1998-07-07 2002-09-05 Dan Michael D. Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
US6344443B1 (en) 1998-07-08 2002-02-05 University Of South Florida Peptide antagonists of tumor necrosis factor alpha
US7605149B1 (en) 1998-07-13 2009-10-20 University Of South Florida Modulation of the phospholipase A2 pathway as a therapeutic
DE69904941D1 (en) 1998-07-21 2003-02-20 Danisco As Kopenhagen Koebenha foods
JP2002521666A (en) * 1998-07-21 2002-07-16 バースタイン テクノロジーズ,インコーポレイティド Assay device and method for the optical disc based
US6312689B1 (en) 1998-07-23 2001-11-06 Millennium Pharmaceuticals, Inc. Anti-CCR2 antibodies and methods of use therefor
US20010018514A1 (en) * 1998-07-31 2001-08-30 Mcgall Glenn H. Nucleic acid labeling compounds
US6187563B1 (en) 1998-08-07 2001-02-13 Yale University βIV-spectrin-polypeptides and nucleic acids encoding same
EP1114153A2 (en) * 1998-09-18 2001-07-11 The Rockefeller University Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof
WO2000017362A1 (en) 1998-09-21 2000-03-30 Schering Corporation Human interleukin-b50, therapeutic uses
EP0997476A3 (en) 1998-09-25 2000-07-19 Schering-Plough Antibodies to a mammalian Langerhans cell antigen and their uses
US6780609B1 (en) 1998-10-23 2004-08-24 Genome Therapeutics Corporation High bone mass gene of 1.1q13.3
WO2002069977A1 (en) 2001-03-01 2002-09-12 Hollis-Eden Pharmaceuticals, Inc. Use of certain steroids for treatment of blood cell deficiencies
US6544792B1 (en) * 1999-12-21 2003-04-08 Genencor International, Inc. Production of secreted polypeptides
EP2341144A1 (en) 1999-01-11 2011-07-06 Schering Corporation Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses
DE60043534D1 (en) 1999-02-04 2010-01-28 Pluristem Ltd METHOD AND DEVICE FOR CONTAINMENT AND EXPANSION OF STEM CELLS hematopoietic AND / OR progenitor cells
US6156515A (en) * 1999-02-09 2000-12-05 Urocor, Inc. Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
ES2319958T3 (en) 1999-03-11 2009-05-18 Schering Corporation Mammalian cytokines: reagents and associated procedures.
GB9907461D0 (en) 1999-03-31 1999-05-26 King S College London Neurite regeneration
EP2341143A1 (en) 1999-05-13 2011-07-06 Medical Research Council OX2 receptor homolog
WO2000069898A8 (en) 1999-05-14 2001-10-18 Arbor Vita Corp Molecular interactions in allergy cells
US6440682B1 (en) * 1999-05-28 2002-08-27 Detroit R&D Inc. Detection of hypertension using immunoreactive metabolic products
US6787318B1 (en) 1999-06-01 2004-09-07 Roskamp Research Institute, Llc Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
EP2258849A1 (en) 1999-06-01 2010-12-08 Schering Corporation Mammalian receptor proteins; related reagents and methods
US7534605B2 (en) * 1999-06-08 2009-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
GB9914210D0 (en) 1999-06-17 1999-08-18 Danisco Promoter
CA2435411A1 (en) * 1999-06-25 2001-01-04 Yissum Research Development Company Of The Hebrew University Of Jerusale M Method of inducing angiogenesis by micro-organs
US20060127366A1 (en) * 1999-06-25 2006-06-15 Mitrani Eduardo N Method and device for inducing biological processes by micro-organs
US6531130B1 (en) 1999-07-06 2003-03-11 The Board Of Trustees Of The Leland Stanford University Treatment of demyelinating autoimmune disease with ordered peptides
DK1200592T3 (en) 1999-07-30 2009-12-07 Schering Corp Mammalian cytokines and Related Reagents
US6875582B1 (en) 1999-08-19 2005-04-05 Omniscience Pharmaceuticals, Inc. Methods and targets of antibiotic resistance
US7811981B2 (en) * 1999-08-30 2010-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of and compositions for inhibiting the proliferation of mammalian cells
US7101839B1 (en) 1999-08-30 2006-09-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of and compositions for inhibiting the proliferation of mammalian cells
EP1905832A3 (en) 1999-09-09 2009-09-09 Schering Corporation Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
DK1218489T3 (en) 1999-09-24 2009-06-02 Cybios Llc Pluripotent embryonic-like stem cells, compositions, methods and use thereof
US6998232B1 (en) 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
US7332275B2 (en) 1999-10-13 2008-02-19 Sequenom, Inc. Methods for detecting methylated nucleotides
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
ES2272333T3 (en) * 1999-11-19 2007-05-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Process for increasing the level of a substance fermentation.
JP2003516324A (en) 1999-11-24 2003-05-13 シェーリング コーポレイション How to inhibit metastasis
EP1247095B1 (en) 1999-12-06 2008-10-15 Board Of Trustees Of The University Of Illinois High affinity tcr proteins and methods
US6544506B2 (en) 2000-01-05 2003-04-08 Yeda Research & Development Co. Ltd. Veto cells effective in preventing graft rejection and devoid of graft versus host potential
EP1252292A4 (en) * 2000-01-24 2004-11-17 Univ Ramot Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
DE10003734A1 (en) * 2000-01-28 2001-08-02 Bosch Gmbh Robert Detection method and apparatus
WO2001062942A3 (en) * 2000-02-25 2002-03-21 Ludwig Inst Cancer Res MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS
US20040002068A1 (en) 2000-03-01 2004-01-01 Corixa Corporation Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
US7875442B2 (en) * 2000-03-24 2011-01-25 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US7829313B2 (en) * 2000-03-24 2010-11-09 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
EP1294748B1 (en) 2000-03-27 2010-06-30 Technion Research and Development of Foundation, Ltd. Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
DE60142508D1 (en) 2000-03-31 2010-08-19 Scripps Research Inst Human aminoacyl-tRNA synthetase polypeptide for the regulation of angiogenesis
US20030108927A1 (en) * 2000-04-03 2003-06-12 Kathryn Leishman Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
US20030220475A1 (en) * 2001-04-03 2003-11-27 Fields Howard A. Neutralizing immunogenic hev polypepetides
EP1274450B1 (en) 2000-04-18 2008-12-10 Schering Corporation Medical uses of agonsist and antagonists of IL-174
EP1287130B2 (en) 2000-05-10 2017-07-26 Merck Sharp & Dohme Corp. Mammalian cytokine receptor subunit proteins, related reagents and methods
US7422743B2 (en) 2000-05-10 2008-09-09 Schering Corporation Mammalian receptor protein DCRS5;methods of treatment
US20030031675A1 (en) 2000-06-06 2003-02-13 Mikesell Glen E. B7-related nucleic acids and polypeptides useful for immunomodulation
US6958214B2 (en) * 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
CA2417357A1 (en) 2000-08-08 2002-02-14 St. Jude Children's Research Hospital Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
ES2387329T3 (en) 2000-08-08 2012-09-20 Technion Research And Development Foundation Ltd. pharmaceutical compositions and methods useful for modulating angiogenesis
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
EP1683874A3 (en) 2000-08-29 2006-10-11 YEDA RESEARCH AND DEVELOPMENT Co. LTD. Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
US6673623B1 (en) 2000-09-12 2004-01-06 Novocure, Inc. Methods and compositions that control lipid production
US7632522B2 (en) 2000-09-28 2009-12-15 Nanocyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
US20070281037A9 (en) * 2000-09-28 2007-12-06 Nanocyte Inc. Sterile preparations and compositions including stinging capsules and methods of producing and using same
US7045283B2 (en) 2000-10-18 2006-05-16 The Regents Of The University Of California Methods of high-throughput screening for internalizing antibodies
US7163800B2 (en) * 2000-11-03 2007-01-16 Molecular Devices Corporation Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US20050136431A1 (en) * 2000-11-03 2005-06-23 Oakley Robert H. Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US7018812B2 (en) * 2000-11-03 2006-03-28 Duke University Modified G-protein coupled receptors
US6890734B2 (en) 2000-11-10 2005-05-10 Schering Corporation Nucleic acids encoding a cytokine receptor complex
CN100457190C (en) 2000-11-17 2009-02-04 脉管生物生长有限公司 Promoters exhibiting endothelial cell specificity and methods of using same
US8071740B2 (en) 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
JP4162486B2 (en) 2000-11-24 2008-10-08 ヴァスキュラー バイオジェニックス リミテッド Compositions containing method and such oxidized phospholipids using a defined oxidized phospholipids for preventing and treating atherosclerosis
US20040248093A1 (en) * 2000-11-27 2004-12-09 Coombs James Howard Magneto-optical bio-discs and systems including related methods
US20030003464A1 (en) * 2000-11-27 2003-01-02 Phan Brigitte C. Dual bead assays including optical biodiscs and methods relating thereto
US20020172980A1 (en) * 2000-11-27 2002-11-21 Phan Brigitte Chau Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
EP1337640A2 (en) * 2000-11-29 2003-08-27 Lynkeus Bio Tech GmbH NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379
KR20030067696A (en) 2000-11-30 2003-08-14 모렉큐랄 스킨케어 리미티드 Diagnosis and treatment of disease
US20020165149A1 (en) * 2000-12-08 2002-11-07 Kranz David M. Mutated class II major histocompatibility proteins
US7087395B1 (en) 2001-01-16 2006-08-08 Quest Diagnostics Investments Incorporated Vitamin D assay
GB0101762D0 (en) * 2001-01-23 2001-03-07 Medical Res Council Method
US20050202098A1 (en) 2001-01-31 2005-09-15 Tolaren Disease therapy using dying or dead cells
DE60325382D1 (en) 2002-09-09 2009-01-29 Arbor Vita Corp A method for diagnosis of cervical cancer
US20030104410A1 (en) * 2001-03-16 2003-06-05 Affymetrix, Inc. Human microarray
US20030003454A1 (en) 2001-03-23 2003-01-02 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
US20040121442A1 (en) * 2002-05-05 2004-06-24 Ilan Chet Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
EP2335728A1 (en) 2001-05-11 2011-06-22 Ludwig Institute for Cancer Research Ltd. Specific binding proteins and uses thereof
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
US20110313230A1 (en) 2001-05-11 2011-12-22 Terrance Grant Johns Specific binding proteins and uses thereof
JP4309137B2 (en) 2001-05-18 2009-08-05 ダニスコ エイ/エス Process for the preparation of dough Using enzymes
GB0112226D0 (en) * 2001-05-18 2001-07-11 Danisco Method of improving dough and bread quality
US7132401B2 (en) 2001-05-22 2006-11-07 Merck & Co., Inc. Beta-secretase substrates and uses thereof
US7553484B2 (en) * 2001-06-05 2009-06-30 The Regents Of The University Of California Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule
US20090324612A1 (en) * 2001-06-05 2009-12-31 Kaufman Daniel L Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
US6770622B2 (en) 2001-06-08 2004-08-03 Gary A. Jarvis N-terminally truncated galectin-3 for use in treating cancer
US20070190534A1 (en) * 2001-06-11 2007-08-16 Genesis Genomics Inc. Mitochondrial sites and genes associated with prostate cancer
WO2003008534A3 (en) * 2001-07-19 2003-11-13 Joseph Hirschberg Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
JP2004536614A (en) * 2001-08-01 2004-12-09 ユニバーシティ オブ ユタUniversity Of Utah Pde3 cyclic nucleotide phosphodiesterase isoform selective inhibitors and activators
US6833441B2 (en) * 2001-08-01 2004-12-21 Abmaxis, Inc. Compositions and methods for generating chimeric heteromultimers
US20030082596A1 (en) * 2001-08-08 2003-05-01 Michael Mittmann Methods of genetic analysis of probes: test3
US20060073530A1 (en) * 2001-08-15 2006-04-06 Olaf Schneewind Methods and compositions involving sortase B
US20040136972A1 (en) 2001-09-07 2004-07-15 Yeda Research And Development Co. Ltd. Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
US7138144B2 (en) * 2001-09-07 2006-11-21 Nadir Askenasy Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
DE60233744D1 (en) 2001-09-20 2009-10-29 Univ Texas Determining circulating therapeutic antibodies, antigens and antigen-antibody complexes with ELISA tests
US7393696B2 (en) * 2001-09-28 2008-07-01 Aspenbio Pharma, Inc. Bovine pregnancy test
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
WO2003033514A1 (en) 2001-10-19 2003-04-24 Vascular Biogenics Ltd. Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
US7175983B2 (en) * 2001-11-02 2007-02-13 Abmaxis, Inc. Adapter-directed display systems
CA2467904C (en) 2001-11-20 2009-04-07 The Curators Of The University Of Missouri Compositions and methods for accurate early pregnancy diagnosis
US6952704B2 (en) * 2001-11-26 2005-10-04 Microsoft Corporation Extending a directory schema independent of schema modification
US8178128B2 (en) * 2001-12-05 2012-05-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Nanoparticles containing polymeric nucleic acid homologs
WO2003054155A3 (en) * 2001-12-19 2004-07-29 Paul M Cino Pichia pastoris formate dehydrogenase and uses therefor
US20050085432A1 (en) * 2001-12-26 2005-04-21 Aviva Lapidot Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
WO2003063110A1 (en) * 2002-01-16 2003-07-31 Regents Of The University Of Minnesota Marker for psychiatric conditions
US20050054097A1 (en) * 2002-11-17 2005-03-10 Tony Peled EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
WO2003078567B1 (en) * 2002-03-18 2004-07-08 Gamida Cell Ltd Methods of inducing differentiation in ex vivo expanded stem cells
WO2003062404A1 (en) 2002-01-25 2003-07-31 Gamida-Cell Ltd. Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
WO2003062278A1 (en) 2002-01-25 2003-07-31 G2 Therapies Ltd MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
US7781396B2 (en) * 2002-01-31 2010-08-24 Tel Aviv University Future Technology Development L.P. Peptides directed for diagnosis and treatment of amyloid-associated disease
EP1487865A4 (en) 2002-02-01 2005-12-14 Schering Corp USES OF MAMMALIAN CYTOKINEi; RELATED REAGENTS
US6992176B2 (en) * 2002-02-13 2006-01-31 Technion Research & Development Foundation Ltd. Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
WO2003070752A3 (en) * 2002-02-20 2004-04-15 Dyax Corp Mhc-peptide complex binding ligands
US7053188B2 (en) 2002-02-22 2006-05-30 Purdue Research Foundation Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
WO2004078917A3 (en) * 2003-03-07 2005-10-27 Gamida Cell Ltd Expansion of renewable stem cell populations using modulators of pi 3-kinase
US20030182669A1 (en) * 2002-03-19 2003-09-25 Rockman Howard A. Phosphoinositide 3-kinase mediated inhibition of GPCRs
US7332585B2 (en) 2002-04-05 2008-02-19 The Regents Of The California University Bispecific single chain Fv antibody molecules and methods of use thereof
US7534580B2 (en) * 2002-05-01 2009-05-19 Ambrilia Biopharma Inc. PSP94 diagnostic reagents and assays
CA2391438A1 (en) * 2002-05-01 2003-11-01 Procyon Biopharma Inc. Psp94 diagnostic reagents and assays
WO2003093296A3 (en) 2002-05-03 2004-09-10 Andreas Braun Kinase anchor protein muteins, peptides thereof, and related methods
JP4646625B2 (en) 2002-05-30 2011-03-09 メモリアル スローン−ケタリング キャンサー センター Ras inactivation kinase suppressor for the treatment of Ras-mediated tumorigenicity
US7785898B2 (en) * 2002-05-31 2010-08-31 Genetic Technologies Limited Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
US7290215B2 (en) * 2002-06-03 2007-10-30 Microsoft Corporation Dynamic wizard interface system and method
US7504215B2 (en) 2002-07-12 2009-03-17 Affymetrix, Inc. Nucleic acid labeling methods
US6916474B2 (en) 2002-07-15 2005-07-12 Board Of Regents, The University Of Texas System Antibodies with increased affinities for anthrax antigens
KR20110027849A (en) 2002-07-15 2011-03-16 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 Peptides binding to phosphatidylethanolamine and their use in treating viral infections and cancer
US7794716B2 (en) 2002-07-25 2010-09-14 Glenveigh Pharmaceuticals, Llc Antibody composition and passive immunization against pregnancy-induced hypertension
EP2298315A1 (en) 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Therapeutic treatment methods
US20040052928A1 (en) * 2002-09-06 2004-03-18 Ehud Gazit Peptides and methods using same for diagnosing and treating amyloid-associated diseases
EP2371955A1 (en) 2002-09-26 2011-10-05 K.U. Leuven Research & Development Integrase cofactor
US7267981B2 (en) 2002-10-07 2007-09-11 Technion Research & Development Foundation Ltd. Human foreskin fibroblasts for culturing ES cells
JP2006514614A (en) 2002-10-24 2006-05-11 ステリックス リミテッド 11β- hydroxysteroid dehydrogenase type 1 and type 2 inhibitor
JP5271475B2 (en) * 2002-11-26 2013-08-21 ザ ユニヴァーシティー オヴ シカゴ Materials and methods for the prevention and treatment of microbial mediated epithelial disorders
WO2004050826A3 (en) * 2002-11-29 2005-02-17 Technion Res & Dev Foundation Method of dynamically culturing embryonic stem cells
EP2194147B1 (en) 2002-12-04 2015-07-22 Applied Biosystems, LLC Multiplex amplification of polynucleotides
US7491699B2 (en) * 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
EP1583512B3 (en) 2002-12-12 2012-12-05 R.B.T. (Rakuto Bio Technologies) Ltd. USE of LIGNIN PEROXIDASE IN SKIN AND HAIR LIGHTENING
ES2571355T3 (en) 2002-12-16 2016-05-24 Technion Res & Dev Foundation Culture system without feeder cells or xenocontaminantes human embryonic stem cells
JP2006512079A (en) 2003-01-02 2006-04-13 ラッパポート・ファミリー・インスティチュート・フォー・リサーチ・イン・ザ・メディカル・サイエンシズRappaport Family Institute For Research In The Medicalsciences Method of predicting the effectiveness of antioxidant treatment to prevent heart disease hyperglycemic patients
US20040229245A1 (en) * 2003-01-06 2004-11-18 Anton Bittner Methods and algorithms for performing quality control during gene expression profiling on DNA microarray technology
EP1583713B1 (en) * 2003-01-07 2009-03-25 Ramot at Tel Aviv University Ltd. Peptide nanostructures encapsulating a foreign material and method of manufacturing same
US20050196766A1 (en) 2003-12-24 2005-09-08 Soe Jorn B. Proteins
DE602004030000D1 (en) 2003-01-17 2010-12-23 Danisco A method for in-situ production of an emulsifier in a foodstuff
US7955814B2 (en) 2003-01-17 2011-06-07 Danisco A/S Method
ES2661213T3 (en) 2003-01-17 2018-03-28 Dupont Nutrition Biosciences Aps Method for the in situ production of an emulsifier in a foodstuff
US7718408B2 (en) * 2003-12-24 2010-05-18 Danisco A/S Method
US7615610B2 (en) * 2003-01-24 2009-11-10 Duke University Modified trafficking patterns for arrestin and G-protein-coupled receptors via arrestin-ubiquitin chimera
JP2007501407A (en) * 2003-03-03 2007-01-25 バースタイン テクノロジーズ,インコーポレイティド The use of optical bio-disc for performing the method, apparatus, and this is used in detection and quantification of diverse cell types
EP1599598A4 (en) 2003-03-04 2007-08-08 Yeda Res & Dev Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same
US8394582B2 (en) * 2003-03-05 2013-03-12 Genetic Technologies, Inc Identification of fetal DNA and fetal cell markers in maternal plasma or serum
WO2004096157A3 (en) 2003-03-07 2005-10-20 New England Medical Center Inc Treatment of igai deposition diseases
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US8017113B2 (en) 2003-03-12 2011-09-13 Rappaport Family Institute For Research In The Medical Sciences Compositions and methods for diagnosing and treating an inflammation
CN101072797B (en) 2004-03-12 2012-05-09 瓦斯基因治疗公司 Antibody binding EPHB4, inhibiting angiogenesis and tumor growth
US20040191260A1 (en) * 2003-03-26 2004-09-30 Technion Research & Development Foundation Ltd. Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
US7294701B2 (en) * 2003-04-02 2007-11-13 Technion Research & Development Foundation Ltd. Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
EP2330132B1 (en) 2003-04-04 2013-08-14 Yeda Research and Development Co. Ltd. Antibodies against MMP2 or MMP9 and pharmaceutical compositions containing same useful for inhibiting activity of said metalloproteins
US8252588B2 (en) 2003-04-08 2012-08-28 Yeda Research And Development Co. Ltd. Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
FR2853551B1 (en) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement stabilizing formulation to immunoglobulin compositions g in liquid form and lyophilized form
US20040209246A1 (en) * 2003-04-15 2004-10-21 Agouron Pharmaceuticals, Inc. Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
US7554007B2 (en) 2003-05-22 2009-06-30 Evogene Ltd. Methods of increasing abiotic stress tolerance and/or biomass in plants
US20050020499A1 (en) * 2003-05-27 2005-01-27 Bar Ilan University Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
WO2005000087A3 (en) * 2003-06-03 2006-02-09 Chiron Corp Gene products differentially expressed in cancerous colon cells and their methods of use ii
US8129514B2 (en) * 2003-06-19 2012-03-06 Evogene Ltd. Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
US7498428B2 (en) * 2003-06-19 2009-03-03 Evogene Ltd. Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
CA2530927A1 (en) 2003-06-30 2005-01-06 Tel Aviv University Future Technology Development L.P. Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
JP2007511738A (en) 2003-08-08 2007-05-10 ジーンニュース インコーポレーテッド Biomarkers and uses thereof osteoarthritis
US20050064479A1 (en) * 2003-08-12 2005-03-24 Affymetrix, Inc. Compounds and methods for post incorporation labeling of nucleic acids
WO2005029091A3 (en) 2003-09-15 2005-09-15 Oklahoma Med Res Found Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
US20050064435A1 (en) * 2003-09-24 2005-03-24 Xing Su Programmable molecular barcodes
WO2005031362A3 (en) 2003-10-02 2005-09-22 Univ Ramot Novel antibacterial agents and methods of identifying and utilizing same
WO2005033145A8 (en) 2003-10-07 2005-12-15 Parameswaran Ramakrishnan Antibodies to nik, their preparation and use
US20050227251A1 (en) 2003-10-23 2005-10-13 Robert Darnell Method of purifying RNA binding protein-RNA complexes
CA2542221A1 (en) * 2003-10-23 2005-05-06 Pfizer Products Inc. Vaccine for periodontal disease
WO2005047324A2 (en) 2003-11-10 2005-05-26 Schering Corp Interleukin-10 antibodies
WO2005051423A3 (en) 2003-11-30 2005-12-15 Yeda Res & Dev Methods and agents for immune modulation and methods for identifying immune modulators
EP2135619A1 (en) 2003-12-10 2009-12-23 Millennium Pharmaceuticals, Inc. Humanized anti-CCR2 antibodies and methods of use therefor
WO2005059100A3 (en) * 2003-12-12 2005-12-15 Univ New York Methods and compositions relating to cystatin c
US20100221233A1 (en) * 2003-12-15 2010-09-02 University Of South Florida Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
EP2289567A3 (en) 2003-12-22 2011-06-22 Regentis Biomaterials Ltd. Matrix comprising naturally-occurring crosslinked protein backbone
US7399467B2 (en) 2003-12-23 2008-07-15 Arbor Vita Corporation Antibodies for oncogenic strains of HPV and methods of their use
US8007847B2 (en) 2004-01-13 2011-08-30 Eytan Biderman Feeding formula appliance
US7423139B2 (en) * 2004-01-20 2008-09-09 Insight Biopharmaceuticals Ltd. High level expression of recombinant human erythropoietin having a modified 5′-UTR
US20050186646A1 (en) * 2004-01-26 2005-08-25 Cruz Miguel A. Rapid assay to detect ADAMTS-13 activity
WO2005071058A3 (en) * 2004-01-27 2007-11-08 Compugen Ltd Methods and systems for annotating biomolecular sequences
CA2555208A1 (en) * 2004-02-18 2005-09-01 Merck & Co., Inc. Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof
GB0403864D0 (en) 2004-02-20 2004-03-24 Ucl Ventures Modulator
US7767792B2 (en) 2004-02-20 2010-08-03 Ludwig Institute For Cancer Research Ltd. Antibodies to EGF receptor epitope peptides
EP2208797A3 (en) 2004-03-01 2010-11-24 Applied Biosystems, LLC Methods, compositions and kits for use in polynucleotide amplification
US7456149B2 (en) 2004-03-02 2008-11-25 Acceleron Pharma, Inc. ALK7 and myostatin inhibitors and uses thereof
GB0405637D0 (en) 2004-03-12 2004-04-21 Danisco Protein
WO2006073430A3 (en) * 2004-04-20 2006-12-07 John C Alverdy Therapeutic delivery system comprising a high molecular weight peg-like compound
EP1766095B1 (en) 2004-05-18 2013-10-23 The Board of Trustees of the Leland Stanford Junior University Detection of protein translocation by beta-galactosidase reporter fragment complementation
CA2570195C (en) 2004-06-14 2017-10-24 Evogene Ltd. Polynucleotides and polypeptides involved in plant fiber development and methods of using same
US8034553B2 (en) 2004-06-24 2011-10-11 Kimberly-Clark Worldwide, Inc. Biomarkers for wound healing
US8680062B2 (en) 2004-07-06 2014-03-25 Deliversir Ltd. System for delivering therapeutic agents into living cells and cells nuclei
US20090156471A1 (en) * 2004-07-15 2009-06-18 Ramot At Tel Aviv University Ltd. Use of anti-amyloid agents for treating and typing pathogen infections
DK1776455T3 (en) 2004-07-16 2015-06-22 Dupont Nutrition Biosci Aps Lipolytic enzyme uses thereof in the food industry
WO2006014798A3 (en) * 2004-07-27 2006-07-27 Thomas Lufkin Methods and compositions for using sax2
EP1789437A4 (en) * 2004-07-30 2008-11-05 Sinai School Medicine Npc1l1 and npc1l1 inhibitors and methods of use thereof
US20060073168A1 (en) * 2004-08-11 2006-04-06 Stephens David S Neisseria meningitidis serogroup a capsular polysaccharide acetyltransferase, methods and compositions
EP1791959A4 (en) * 2004-08-26 2009-03-18 Enegenic Gene Therapy Pty Ltd Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
FI20050753A (en) 2004-09-03 2006-03-04 Licentia Oy New peptides
JP4933435B2 (en) 2004-09-14 2012-05-16 ザ ユニバーシティー オブ シンシナティ Bucindolol treatment method based on gene targeting
WO2006030442A3 (en) 2004-09-16 2009-02-05 Gamida Cell Ltd Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
EP3312282A1 (en) 2004-09-29 2018-04-25 Collplant Ltd. Collagen producing plants and methods of generating and using same
ES2524601T3 (en) * 2004-09-29 2014-12-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. RNase T2 recombinant human and uses thereof
GB0422052D0 (en) 2004-10-04 2004-11-03 Dansico As Enzymes
US7390489B2 (en) * 2004-10-08 2008-06-24 Komed Co., Ltd. Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody
EP1809374A4 (en) * 2004-10-12 2008-09-10 Closed Loop Therapies Ltd Methods and implantable devices for treating supraventricular arrhythmias
GB0423139D0 (en) * 2004-10-18 2004-11-17 Danisco Enzymes
WO2006050270A3 (en) * 2004-11-02 2006-08-10 Us Gov Health & Human Serv Compositions and methods for treating hyperproliferative disorders
GB0424940D0 (en) 2004-11-11 2004-12-15 Danisco Transcription factors
US8288128B2 (en) * 2004-11-18 2012-10-16 Eppendorf Array Technologies S.A. Real-time quantification of multiple targets on a micro-array
EP1812594B1 (en) 2004-11-18 2013-01-09 Eppendorf Array Technologies Real-time quantification of multiple targets on a micro-array
US7504769B2 (en) * 2004-12-16 2009-03-17 E. I. Du Pont De Nemours + Company Aromatic chalcogen compounds and their use
US20060134680A1 (en) * 2004-12-22 2006-06-22 Alexander Kotlyar Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
EP1982450A2 (en) * 2006-01-16 2008-10-22 Zlango Ltd. Communications network system and methods for using same
WO2007080559A3 (en) 2006-01-16 2009-03-26 Zlango Ltd Iconic communication
JP2008527563A (en) 2005-01-16 2008-07-24 ズランゴー リミテッド Iconic communication
US20080082678A1 (en) * 2005-01-16 2008-04-03 Zlango Ltd. Communications Network System and Methods for Using Same
EP1846577B1 (en) 2005-02-07 2012-07-04 GeneNews Inc. Method of diagnosing osteoarthritis employing the biomarkers IL13RA1 and CPT1A
EP2316441A1 (en) 2005-02-17 2011-05-04 Hadasit Medical Research Services And Development Bisphosphonates for treating endometriosis
GB0503546D0 (en) * 2005-02-21 2005-03-30 Hellenic Pasteur Inst Antibody
JP5432455B2 (en) 2005-02-25 2014-03-05 ザ ステート オブ イスラエル、ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント、アグリカルチュラル リサーチ オーガナイゼイション、(エー.アール.オー.)、ボルカニ センター Fruit cell culture extracts for the treatment of inflammation
US7695927B2 (en) * 2005-03-18 2010-04-13 Detroit R & D Detection of hypertension using glucuronidated metabolic products
EP1863848A4 (en) 2005-03-31 2009-09-23 Agensys Inc Antibodies and related molecules that bind to 161p2f10b proteins
ES2536915T3 (en) 2005-04-04 2015-05-29 Biogen Idec Ma Inc. Methods and products for assessing an immune response to a therapeutic protein
EP2674440A3 (en) 2005-12-16 2014-03-05 IBC Pharmaceuticals, Inc. Multivalent immunoglobulin-based bioactive assemblies
US20090068207A1 (en) * 2005-04-15 2009-03-12 Vascular Biogenics Ltd. Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease
ES2354452T3 (en) 2005-04-18 2011-03-15 Mitomics Inc. Reorganizations and mitochondrial mutations as tools for detecting Diagnostic Checks sun exposure, prostate cancer and other cancers.
US8834862B2 (en) * 2005-04-19 2014-09-16 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
CN101175856A (en) 2005-05-12 2008-05-07 诺瓦提斯公司;莫道什大学 Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
EP2279726A3 (en) 2005-05-26 2012-06-20 Biorest Ltd. Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
EP1893747B1 (en) 2005-06-16 2014-09-03 Ramot at Tel Aviv University Ltd. Isolated cells and populations comprising same for the treatment of cns diseases
CN104673905B (en) 2005-06-20 2016-09-07 领先细胞医疗诊断有限公司 Detecting nucleic acids in single cell large cell population and identification of rare cells in a heterogeneous method
US20070225242A1 (en) * 2005-06-21 2007-09-27 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for treating and preventing tumor metastasis in vivo
US9051379B2 (en) 2005-07-07 2015-06-09 Fulcrum Sp Ltd. Sp1 polypeptides, modified Sp1 polypeptides and uses thereof
US8067573B2 (en) * 2005-07-07 2011-11-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nucleic acid agents for downregulating H19 and methods of using same
EP2484768A3 (en) 2005-07-18 2012-11-21 Protalix Ltd. Mucosal or enteral administration of biologically active macromolecules
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
WO2007023491A3 (en) 2005-08-24 2009-01-08 Yeda Res & Dev Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
US7608395B2 (en) 2005-09-15 2009-10-27 Baylor Research Institute Systemic lupus erythematosus diagnostic assay
WO2007034487B1 (en) 2005-09-22 2007-08-23 Yissum Res Dev Co Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
WO2007041340A3 (en) * 2005-09-30 2007-11-01 Univ Columbia Microfluidic cells with parallel arrays of individual dna molecules
US20070202515A1 (en) * 2005-10-12 2007-08-30 Pathologica, Llc. Promac signature application
US20070087437A1 (en) * 2005-10-14 2007-04-19 Jifan Hu Methods for rejuvenating cells in vitro and in vivo
US7842823B2 (en) * 2005-10-27 2010-11-30 The Regents Of The University Of California Fluorogenic probes for reactive oxygen species
US8101741B2 (en) 2005-11-02 2012-01-24 Protiva Biotherapeutics, Inc. Modified siRNA molecules and uses thereof
EP1945261A4 (en) 2005-11-07 2010-05-12 Scripps Research Inst Compositions and methods for controlling tissue factor signaling specificity
US8124351B2 (en) 2005-11-18 2012-02-28 Board Of Regents, The University Of Texas System Quantification of fusion proteins and their activity from chromosomal translocation
EP2390312A1 (en) 2005-11-29 2011-11-30 Gamida Cell Ltd. Methods of improving stem cell homing and engraftment
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
WO2007067968A3 (en) 2005-12-08 2007-08-23 Carla Heise Effects of inhibitors of fgfr3 on gene transcription
US20070134814A1 (en) * 2005-12-09 2007-06-14 Kajander E O Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
US7465544B2 (en) * 2006-01-11 2008-12-16 Wisconsin Alumni Research Foundation Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
CA2640423C (en) 2006-01-27 2016-03-15 Biogen Idec Ma Inc. Nogo receptor antagonists
US20070179094A1 (en) 2006-01-31 2007-08-02 Bayer Schering Pharma Ag Modulation of MDL-1 activity for treatment of inflammatory disease
US8048848B2 (en) 2006-02-03 2011-11-01 Prolor Biotech Ltd. Long-acting interferons and derivatives thereof and methods thereof
US9249407B2 (en) 2006-02-03 2016-02-02 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US8450269B2 (en) 2006-02-03 2013-05-28 Prolor Biotech Ltd. Long-acting growth hormone and methods of producing same
US9663778B2 (en) 2009-07-09 2017-05-30 OPKO Biologies Ltd. Long-acting coagulation factors and methods of producing same
US20150038413A1 (en) 2006-02-03 2015-02-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US20140113860A1 (en) 2006-02-03 2014-04-24 Prolor Biotech Ltd. Long-acting polypeptides and methods of producing and administering same
US8946155B2 (en) 2006-02-03 2015-02-03 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US8759292B2 (en) 2006-02-03 2014-06-24 Prolor Biotech, Llc Long-acting coagulation factors and methods of producing same
US7553941B2 (en) 2006-02-03 2009-06-30 Modigene Inc Long-acting polypeptides and methods of producing same
US8048849B2 (en) 2006-02-03 2011-11-01 Modigene, Inc. Long-acting polypeptides and methods of producing same
US9458444B2 (en) 2006-02-03 2016-10-04 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US8476234B2 (en) 2006-02-03 2013-07-02 Prolor Biotech Inc. Long-acting coagulation factors and methods of producing same
US20090197286A1 (en) 2006-02-06 2009-08-06 Rappaport Family Institute For Research In The Med Methods and Kit for Diagnosing T1DM
WO2007102146A3 (en) 2006-03-06 2007-11-29 Zetiq Technologies Ltd Methods and compositions for identifying a cell phenotype
WO2007109733A3 (en) 2006-03-21 2008-01-24 Univ Johns Hopkins Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
WO2012127320A1 (en) 2011-03-22 2012-09-27 Pluristem Ltd. Methods for treating radiation or chemical injury
CN105296415A (en) 2006-03-23 2016-02-03 普拉里斯坦有限公司 Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
WO2007110869A3 (en) 2006-03-28 2009-04-16 Tel Hashomer Medical Res Infrastructure & Services Ltd Methods and kits for determining predisposition to warfarin resistance
US20070232556A1 (en) * 2006-03-31 2007-10-04 Montine Thomas J Methods and compositions for the treatment of neurological diseases and disorders
JP2009533028A (en) * 2006-04-07 2009-09-17 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ セクレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ Antibody composition for the treatment of neoplastic disease and methods
EP2636743A1 (en) 2006-04-21 2013-09-11 Intervet International B.V. Pestivirus species
FR2900341B1 (en) 2006-04-27 2012-09-14 Centre Nat Rech Scient Using synthetic multivalent ligands surface nucleolin for the treatment of cancer
CA2651847A1 (en) * 2006-05-09 2007-11-22 Musc Foundation For Research Development Detecting diastolic heart failure by protease and protease inhibitor plasma profiling
US20100196336A1 (en) 2006-05-23 2010-08-05 Dongsu Park Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
US20070281883A1 (en) * 2006-06-05 2007-12-06 Hanna Rosenfeld Development of follicle stimulating hormone agonists and antagonists in fish
US20080003230A1 (en) 2006-07-03 2008-01-03 Adair Charles D Composition for modulating the expression of cell adhesion molecules
RU2009104460A (en) * 2006-07-11 2010-08-20 Маск Фаундейшн Фор Рисерч Дивелопмент (Us) Prediction of heart failure after myocardial infarction in the profile of proteases and protease inhibitors
US20080026394A1 (en) * 2006-07-11 2008-01-31 Antara Biosciences Inc. Methods of detecting one or more cancer markers
JP5266219B2 (en) 2006-07-14 2013-08-21 ケモセントリックス, インコーポレイテッド Triazolyl-phenyl benzene sulfonamides
US8629259B2 (en) 2006-07-20 2014-01-14 Yeda Research And Development Co. Ltd. Photosynthetic organisms and compositions and methods of generating same
US20110184747A1 (en) * 2006-08-09 2011-07-28 Carmen Bozic Method for distribution of a drug
JP2008043332A (en) 2006-08-17 2008-02-28 Panomics Inc Quantitative determination of nucleic acid from tissue slide
EP2051997B1 (en) 2006-08-22 2015-03-18 G2 Inflammation Pty Ltd Anti-c5ar antibodies with improved properties
WO2008023840A3 (en) 2006-08-25 2008-07-17 Yataro Daigo Prognostic markers and therapeutic targets for lung cancer
EP2064319B1 (en) 2006-08-28 2017-02-22 Yeda Research and Development Co. Ltd. Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns
US7951776B2 (en) 2006-09-01 2011-05-31 American Type Culture Collection Methods for treatment of type 1 diabetes
US7985542B2 (en) 2006-09-07 2011-07-26 Institut Pasteur Genomic morse code
ES2457243T3 (en) 2006-09-08 2014-04-25 The Chancellor, Masters And Scholars Of The University Of Oxford Clinical diagnosis of liver fibrosis APOL1 using human serum as a biomarker
US8055034B2 (en) 2006-09-13 2011-11-08 Fluidigm Corporation Methods and systems for image processing of microfluidic devices
US8050516B2 (en) * 2006-09-13 2011-11-01 Fluidigm Corporation Methods and systems for determining a baseline during image processing
US7888059B2 (en) * 2006-10-05 2011-02-15 Yeda Research And Development Co. Ltd. Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
US20100129656A1 (en) 2006-10-05 2010-05-27 Technion Research & Develpment Foundation Ltd Microtubes and methods of producing same
CA2665709C (en) * 2006-10-11 2018-04-03 Janssen Pharmaceutica N.V. Compositions and methods for treating and diagnosing irritable bowel syndrome
EP1912067A1 (en) * 2006-10-12 2008-04-16 Eppendorf Array Technologies S.A. Method for quantification of a target compound obtained from a biological sample upon chips
EP2076591A2 (en) 2006-10-20 2009-07-08 Danisco US, INC., Genencor Division Polyol oxidases
EP2097750A2 (en) * 2006-10-26 2009-09-09 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20100234238A1 (en) 2006-10-27 2010-09-16 Janssen Pharmaceutica N V Method for profiling kinase inhibitors
US8026065B2 (en) 2006-11-02 2011-09-27 Yale University Assessment of oocyte competence
US8293684B2 (en) * 2006-11-29 2012-10-23 Exiqon Locked nucleic acid reagents for labelling nucleic acids
US8473216B2 (en) * 2006-11-30 2013-06-25 Fluidigm Corporation Method and program for performing baseline correction of amplification curves in a PCR experiment
EP2102239B1 (en) 2006-11-30 2012-04-25 Research Development Foundation Improved immunoglobulin libraries
EP2129690A1 (en) 2006-12-14 2009-12-09 Shering Corporation Engineered anti-tslp antibody
CA2672756A1 (en) 2006-12-20 2008-06-26 Evogene Ltd. Polynucleotides and polypeptides involved in plant fiber development and methods of using same
US8506499B2 (en) * 2007-01-04 2013-08-13 Musc Foundation For Research Development Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
CA2674949A1 (en) 2007-01-12 2008-07-24 J. Marc Simard Targeting ncca-atp channel for organ protection following ischemic episode
DK2405007T5 (en) 2007-01-25 2014-06-23 Dupont Nutrition Biosci Aps Preparation of a lipid acyltransferase out of the transformed Bacillus licheniformis cells
EP2111550B1 (en) 2007-01-26 2011-11-30 University Of Louisville Research Foundation, Inc. Methods of detecting autoantibodies for diagnosing and characterizing disorders
WO2008092094A3 (en) * 2007-01-26 2008-12-11 Univ South Florida Method and materials for detection, diagnosis and management of ovarian cancer
US20100196403A1 (en) * 2007-01-29 2010-08-05 Jacob Hochman Antibody conjugates for circumventing multi-drug resistance
WO2008093341A3 (en) 2007-01-31 2009-06-18 Technion Res & Dev Foundation Electrospun scaffolds and methods of generating and using same
CA2676932C (en) 2007-02-01 2015-11-24 Technion Research & Development Foundation Ltd. Albumin fibers and fabrics and methods of generating and using same
US8143046B2 (en) * 2007-02-07 2012-03-27 Danisco Us Inc., Genencor Division Variant Buttiauxella sp. phytases having altered properties
KR100855299B1 (en) * 2007-02-16 2008-08-29 건국대학교 산학협력단 Monoclonal antibodies specific against il-32 antigens, hybridoma producing the monoclonal antibodies and diagnostic systems using the monoclonal antibodies
JP2008203195A (en) * 2007-02-22 2008-09-04 Japan Science & Technology Agency Bsh immunoassay kit and bsh measuring method
WO2008103432A1 (en) 2007-02-23 2008-08-28 Schering Corporation Engineered anti-il-23p19 antibodies
WO2008103473A1 (en) 2007-02-23 2008-08-28 Schering Corporation Engineered anti-il-23p19 antibodies
WO2008106149A1 (en) * 2007-02-28 2008-09-04 Children's Medical Center Corporation Methods for predicting the onset of menarche
WO2008104979A3 (en) 2007-02-28 2010-09-02 Yeda Research And Development Co. Ltd. Nuclear targeting sequences
EP2057194B1 (en) 2007-02-28 2013-03-20 Merck Sharp & Dohme Corp. Engineered anti-il-23r antibodies
US20080220498A1 (en) * 2007-03-06 2008-09-11 Cervin Marguerite A Variant Buttiauxella sp. phytases having altered properties
WO2008109782A3 (en) * 2007-03-06 2009-12-30 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease in children
EP2136843A1 (en) 2007-03-12 2009-12-30 Miraculins Inc. Biomarkers of prostate cancer and uses thereof
WO2008116150A3 (en) 2007-03-21 2008-11-13 Cedars Sinai Medical Center Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease
EP2514766A3 (en) 2007-03-29 2013-06-05 Technion Research & Development Foundation Ltd. Antibodies, methods and kits for diagnosing and treating melanoma
CN101715489B (en) 2007-03-30 2016-05-25 因詹尼克分子递送控股有限公司 For in vivo delivery to a mammalian cell, comprising the plasmid-free functional nucleic acid, the bacterially derived intact minicell
JP2010523104A (en) 2007-04-02 2010-07-15 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッドRamot At Tel Aviv University Ltd. Its use for monitoring the treatment of diagnosis and cancer diseases of cancer cell detection method and cancer diseases
CA2683559A1 (en) 2007-04-13 2008-10-23 Dana Farber Cancer Institute, Inc. Methods for treating cancer resistant to erbb therapeutics
WO2008127707A1 (en) * 2007-04-13 2008-10-23 Dana Farber Cancer Institute, Inc. Receptor tyrosine kinase profiling
US8003314B2 (en) 2007-04-16 2011-08-23 Diagnostic Hybrids, Inc. Methods for direct fluorescent antibody virus detection in liquids
EP2908864A4 (en) 2012-10-22 2016-06-08 Deliversir Ltd A system for delivering therapeutic agents into living cells and cells nuclei
US9556210B2 (en) 2007-04-23 2017-01-31 Sabag-Rfa Ltd. System for delivering therapeutic agents into living cells and cells nuclei
US9156865B2 (en) 2007-04-23 2015-10-13 Deliversir Ltd System for delivering therapeutic agents into living cells and cells nuclei
WO2008137475A3 (en) 2007-05-01 2009-01-08 Res Dev Foundation Immunoglobulin fc libraries
WO2008132753A3 (en) 2007-05-01 2010-02-25 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for detecting fetal cells in the maternal blood
WO2008136774A8 (en) 2007-05-03 2009-07-23 Agency Science Tech & Res Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
WO2008150496A9 (en) * 2007-05-31 2009-04-09 Genelux Corp Assay for sensitivity to chemotherapeutic agents
US7776877B2 (en) 2007-06-22 2010-08-17 Chemocentryx, Inc. N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
US9102754B2 (en) * 2007-06-28 2015-08-11 University Of Saskatchewan Immunomodulatory compositions and methods for treating disease with modified host defense peptides
WO2009009662A1 (en) * 2007-07-10 2009-01-15 University Of South Florida Method of predicting non-response to first line chemotherapy
EP2176409B1 (en) 2007-07-11 2012-01-04 Yeda Research And Development Co. Ltd. Nucleic acid construct systems capable of diagnosing or treating a cell state
DK2175859T3 (en) 2007-07-12 2012-06-18 Chemocentryx Inc Fused heteroarylpyridyl- and phenylbenzene CCR2-sulfonamides as modulators for the treatment of inflammation
WO2009010968A3 (en) 2007-07-15 2009-05-28 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
US8686227B2 (en) 2007-07-24 2014-04-01 Evogene Ltd. Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
ES2534490T3 (en) 2007-08-02 2015-04-23 Gilead Biologics, Inc. LOX and LOXL2 inhibitors and uses thereof
EP3018139A3 (en) 2007-08-03 2016-08-10 Boehringer Ingelheim Vetmedica GmbH Genes and proteins of brachyspira hyodysenteriae and uses thereof
JP5777340B2 (en) 2007-08-06 2015-09-09 オリオン ゲノミクス エルエルシー Single nucleotide polymorphisms and combinations of new and known polymorphisms for determining allele-specific expression of Igf2 gene
CA2695960A1 (en) 2007-08-08 2009-03-12 The Board Of Regents Of The University Of Texas System Vegfr-1/nrp-1 targeting peptides
CN102176914B (en) 2008-08-08 2014-12-17 新加坡科技研究局 VHZ for diagnosis and treatment of cancers
WO2009023676A1 (en) * 2007-08-12 2009-02-19 Integrated Dna Technologies, Inc. Microarray system with improved sequence specificity
US20090136916A1 (en) * 2007-08-13 2009-05-28 Trustees Of Tufts College Methods and microarrays for detecting enteric viruses
RU2474433C2 (en) 2007-08-15 2013-02-10 ЙЕДА РЕСЕАРЧ ЭНД ДЕВЕЛОПМЕНТ КО. ЛТД, эт ве Вайзманн Институте оф Сайнсе Mmp-9 regulators and use thereof
GB0716126D0 (en) * 2007-08-17 2007-09-26 Danisco Process
WO2009072001A2 (en) * 2007-09-12 2009-06-11 Aurelium Biopharma Inc. Slc9a3r1 directed diagnostics for neoplastic disease
EP2511708B1 (en) 2007-10-05 2016-09-14 Affymetrix, Inc. Highly multiplexed particle-based assays
JP2011504374A (en) 2007-11-26 2011-02-10 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド Composition comprising a fibrous polypeptide and polysaccharide
EP2238251B1 (en) 2007-12-27 2015-02-11 Protiva Biotherapeutics Inc. Silencing of polo-like kinase expression using interfering rna
EP2240510B1 (en) 2007-12-27 2017-05-10 Evogene Ltd. Isolated polypeptides, polynucleotides useful for modifying salinity stress tolerance in plants
CA2711499C (en) 2008-01-10 2018-09-25 Research Development Foundation Vaccines and diagnostics for the ehrlichioses
CA2711826C (en) 2008-01-25 2018-02-27 Amgen Inc. Ferroportin antibodies and methods of use
US20090233295A1 (en) * 2008-01-29 2009-09-17 Elias Georges Trim59 directed diagnostics for neoplastic disease
WO2009095925A3 (en) * 2008-01-31 2010-04-15 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
DK2252312T3 (en) 2008-02-07 2014-06-16 Univ Cornell Methods for the prevention or treatment of insulin resistance
WO2009103113A1 (en) 2008-02-20 2009-08-27 G2 Inflammation Pty Ltd HUMANIZED ANTI-C5aR ANTIBODIES
US9464368B2 (en) 2008-02-21 2016-10-11 Technion Research & Development Foundation Ltd. Methods of attaching a molecule-of-interest to a microtube
EP2363407A1 (en) 2008-02-28 2011-09-07 Murdoch University Novel sequences of Brachyspira, immunogenic compositions, methods for preparation and use thereof
US20090311695A1 (en) * 2008-03-12 2009-12-17 Talat Nasim Method
EP3272871A1 (en) 2009-03-27 2018-01-24 MDNA Life Sciences Inc. Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
EP2107125A1 (en) 2008-03-31 2009-10-07 Eppendorf Array Technologies SA (EAT) Real-time PCR of targets on a micro-array
US8747855B2 (en) * 2008-04-09 2014-06-10 Technion Research & Development Foundation Limited Anti human immunodeficiency antibodies and uses thereof
EP2297200A1 (en) * 2008-04-09 2011-03-23 Technion Research & Development Foundation Ltd. Anti influenza antibodies and uses thereof
CN102083615B (en) * 2008-04-10 2014-08-13 战略系统有限公司 System and method for three dimensional model printing
EP2770057A1 (en) 2008-04-15 2014-08-27 Protiva Biotherapeutics Inc. Silencing of CSN5 gene expression using interfering RNA
CA2721333A1 (en) 2008-04-15 2009-10-22 Protiva Biotherapeutics, Inc. Novel lipid formulations for nucleic acid delivery
CN102056619A (en) 2008-04-18 2011-05-11 科尔普兰特有限公司 Methods of generating and using procollagen
GB0807161D0 (en) * 2008-04-18 2008-05-21 Danisco Process
US20090269780A1 (en) * 2008-04-23 2009-10-29 Luminex Corporation Method for Creating a Standard for Multiple Analytes Found in a Starting Material of Biological Origin
EP2281062B1 (en) * 2008-04-24 2017-11-29 The Trustees of Columbia University in the City of New York Geometric patterns and lipid bilayers for dna molecule organization
CN102083996A (en) 2008-04-30 2011-06-01 丹尼斯科公司 Oxidation process
EP2294087B1 (en) 2008-05-01 2014-05-14 Amgen, Inc. Anti-hepcidin antibodies and methods of use
JP2010043063A (en) 2008-05-09 2010-02-25 Agency For Science Technology & Research Diagnosis and treatment of kawasaki disease
JP5548866B2 (en) * 2008-05-22 2014-07-16 サントル ナスィオナル ド ラ ルシェルシュ スィアンティフィク(セ.エン.エル.エス.) Novel optically pure compounds for improving the therapeutic effect
ES2674256T3 (en) 2008-05-22 2018-06-28 Evogene Ltd. Isolated polynucleotides and polypeptides and methods of use thereof for increasing plant yield
US9393273B2 (en) 2008-05-27 2016-07-19 Pluristem Ltd. Methods of treating inflammatory colon diseases
US8663987B2 (en) 2008-05-28 2014-03-04 Ramot At Tel-Aviv University Ltd. Mesenchymal stem cells for the treatment of CNS diseases
US8791258B2 (en) * 2008-06-10 2014-07-29 The Regents Of The University Of California Pro-fluorescent probes
EP2326419A1 (en) 2008-06-29 2011-06-01 Realbio Technologies Ltd. Liquid transfer device particularly useful as a capturing device in a biological assay process
WO2010017544A3 (en) 2008-08-08 2011-03-24 Genisphere, Llc Long - acting dna dendrimers as vectors for the delivery of sirna
EP2326163B1 (en) 2008-08-18 2016-05-04 Evogene Ltd. Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants
US8367392B2 (en) * 2008-09-05 2013-02-05 Transalgae Ltd. Genetic transformation of algal and cyanobacteria cells by microporation
WO2010029545A3 (en) 2008-09-11 2011-03-03 Ben Gurion University Of The Negev Research And Development Authority Compositions and methods for treating s. pneumoniae infection
RU2535966C2 (en) 2008-09-12 2014-12-20 Криопрашис Криобиоложия Лтда. Cell-based therapy of ischemic tissue
WO2010036323A1 (en) 2008-09-25 2010-04-01 University Of Massachusetts Medical School Method of identifing interactions between genomic loci
US20110178024A1 (en) 2008-09-29 2011-07-21 Ben Gurion University Of The Negev Research And Development Authority Amyloid beta-peptides and methods of use thereof
US9207242B2 (en) 2008-10-09 2015-12-08 The University Of Hong Kong Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
CA2743057A1 (en) 2008-11-07 2010-05-14 Research Development Foundation Compositions and methods for the inhibition of cripto/grp78 complex formation and signaling
WO2010055525A1 (en) 2008-11-17 2010-05-20 Technion Research & Development Foundation Ltd. Method for predicting a patient's responsiveness to anti-folate therapy
WO2010058396A1 (en) 2008-11-19 2010-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. A cd44vra antibody and diagnostic and therapeutic methods using same
WO2010061383A1 (en) 2008-11-26 2010-06-03 Biodalia Microbiological Technologies Ltd. A method of in-situ enrichment of foods with fructan
WO2010064231A1 (en) 2008-12-02 2010-06-10 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
US20110287088A1 (en) 2008-12-03 2011-11-24 Research Development Foundation Modulation of olfml-3 mediated angiogenesis
WO2010064247A1 (en) 2008-12-03 2010-06-10 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for determining predisposition to cancer
EP2373301B1 (en) 2008-12-05 2013-11-06 Yeda Research and Development Co. Ltd. Methods of diagnosing motor neuron diseases
EP2373997A1 (en) 2008-12-09 2011-10-12 Dako Denmark A/S Method for evaluating pre-treatment
WO2010068757A1 (en) 2008-12-12 2010-06-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and methods useful for detecting and treating diseases associated with 16p chromosomal disruptions
WO2010071610A1 (en) 2008-12-19 2010-06-24 Agency For Science, Technology And Research (A*Star) Severe chikungunya biomarkers
WO2010075579A3 (en) 2008-12-24 2010-10-14 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy
EP2376653A2 (en) 2008-12-29 2011-10-19 Yissum Research Development Company of The Hebrew University of Jerusalem Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
JP5758302B2 (en) 2008-12-29 2015-08-05 テル ハショメール メディカル リサーチ,インフラストラクチャ アンド サービシーズ リミテッド Peptides and compositions for the prevention of cell adhesion, and methods of use thereof
WO2010076794A1 (en) 2008-12-31 2010-07-08 Technion Research & Development Foundation Ltd. Method of denitrifying brine and systems capable of same
WO2010080769A4 (en) 2009-01-06 2011-02-24 Arresto Biosciences, Inc. Chemotherapeutic methods and compositions
US8691760B2 (en) 2009-02-02 2014-04-08 Ramot At Tel-Aviv University Peptides, pharmaceutical compositions comprising same and uses thereof
WO2010089707A1 (en) 2009-02-04 2010-08-12 Yeda Research And Development Co. Ltd. Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
ES2544265T3 (en) 2009-02-11 2015-08-28 Orion Genomics, Llc Combinations of polymorphisms to determine the specific expression of IGF2 allele
JP2012517238A (en) 2009-02-11 2012-08-02 カリス エムピーアイ インコーポレイテッド Molecular profiling method of tumor
WO2010093450A3 (en) 2009-02-11 2010-12-23 Ludwing Institute For Cancer Research Ltd. Pten phosphorylation-driven restistance to cancer treatment and altered prognosis
US20110306069A1 (en) 2009-02-19 2011-12-15 Qingyu Wu Corin As A Marker For Heart Failure
EP2401363B1 (en) 2009-02-26 2018-08-22 Tel HaShomer Medical Research Infrastructure and Services Ltd. Methods of reprogramming renal cells
EP2403956B1 (en) 2009-03-02 2015-11-25 Evogene Ltd. Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
ES2564265T3 (en) 2009-03-09 2016-03-21 Ramot At Tel-Aviv University Ltd. Compositions for prevention and treatment of neurodegenerative diseases
WO2010103517A1 (en) 2009-03-12 2010-09-16 Rappaport Family Institute For Research In The Medical Sciences Soluble compositions for the treatment of cxcr3-ligand associated diseases
US20100240065A1 (en) * 2009-03-18 2010-09-23 Boehringer Ingelheim International Gmbh Prolyl Hydroxylase Compositions and Methods of Use Thereof
US8481698B2 (en) * 2009-03-19 2013-07-09 The President And Fellows Of Harvard College Parallel proximity ligation event analysis
WO2010113096A1 (en) 2009-03-30 2010-10-07 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods of predicting clinical course and treating multiple sclerosis
CA2759201A1 (en) 2009-04-01 2010-10-07 The Medical Research, Infrastructure, And Health Services Fund Of The Te L Aviv Medical Center A method of regulating proliferation and differentiation of keratinocyes
WO2010116375A1 (en) 2009-04-08 2010-10-14 Yeda Research And Development Co. Ltd. Isolated peptides for regulating apoptosis
EP2421955A4 (en) 2009-04-21 2012-10-10 Genetic Technologies Ltd Methods for obtaining fetal genetic material
GB0908770D0 (en) 2009-04-24 2009-07-01 Danisco Method
RU2598710C2 (en) 2009-04-30 2016-09-27 Тел Хашомер Медикал Рисерч Инфрастракче Энд Сервисиз Лтд. Ceacam1 antibodies and methods for use thereof
US9040667B2 (en) 2009-05-01 2015-05-26 Dako Denmark A/S Antibody cocktail
EP2430451B1 (en) 2009-05-14 2014-08-13 The Chancellors, Masters and Scholars of the University of Oxford Clinical diagnosis of hepatic fibrosis / cirrhosis using low abundant human plasma protein biomarkers
WO2010134073A1 (en) 2009-05-19 2010-11-25 Zetiq Technologies Ltd. Kits for and methods of differential staining of cervical cancer cells and/or tissues
EP2432876A1 (en) 2009-05-19 2012-03-28 Danisco A/S Use
WO2011019423A3 (en) 2009-05-20 2011-05-05 Schering Corporation Modulation of pilr receptors to treat microbial infections
EP2435072A2 (en) 2009-05-27 2012-04-04 Yeda Research and Development Co. Ltd. Proteasome inhibitors and uses thereof
WO2010137013A1 (en) 2009-05-27 2010-12-02 Ramot At Tel Aviv University Ltd. Crystallized photosystem i units from the pea plant and their use in solid state devices
WO2010137021A3 (en) 2009-05-27 2011-03-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method of generating connective tissue
US20120070449A1 (en) 2009-05-28 2012-03-22 Yeda Research And Development Co. Ltd. Methods of treating inflammation
EP2438444A1 (en) 2009-06-02 2012-04-11 The Board of Regents of The University of Texas System Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
EP2440033B1 (en) 2009-06-10 2017-03-15 Evogene Ltd. Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
JP2012531197A (en) 2009-06-25 2012-12-10 デュポン ニュートリション バイオサイエンシーズ エーピーエス protein
CN102725410B (en) 2009-06-29 2016-03-16 西澳大学 From Santalum terpene synthase
EP2449114B9 (en) 2009-07-01 2017-04-19 Protiva Biotherapeutics Inc. Novel lipid formulations for delivery of therapeutic agents to solid tumors
WO2011004379A1 (en) 2009-07-10 2011-01-13 Tel Hashomer Medical Research Infrastructure And Services Ltd. Compositions and methods for treating cancer
DK3042957T3 (en) 2009-07-17 2018-01-02 Bioatla Llc At the same time, integrated selection and development of human protein-performance and expression in production hosts
WO2011011447A1 (en) 2009-07-20 2011-01-27 Protiva Biotherapeutics, Inc. Compositions and methods for silencing ebola virus gene expression
GB0913442D0 (en) 2009-07-31 2009-09-16 Univ Ramot Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
US20120148546A1 (en) 2009-08-17 2012-06-14 Technion Research & Development Foundation Ltd. Pericyte progenitor cells and methods of generating and using same
EP2467146A1 (en) 2009-08-21 2012-06-27 Beeologics Inc. Preventing and curing beneficial insect diseases via plant transcribed molecules
EP2470164B1 (en) 2009-08-27 2017-05-31 Technion Research & Development Foundation Ltd. Liposomal compositions and uses of same
KR20170119746A (en) 2009-09-03 2017-10-27 머크 샤프 앤드 돔 코포레이션 Anti-gitr antibodies
WO2011030332A3 (en) 2009-09-08 2011-06-03 Yeda Research And Development Co. Ltd. Methods for hematopoietic precursor mobilization
WO2011030336A1 (en) 2009-09-08 2011-03-17 Ramot At Tel-Aviv University Ltd. Methods of diagnosing amyotrophic lateral sclerosis (als)
US20120171213A1 (en) 2009-09-10 2012-07-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method of treating tumors
ES2538007T3 (en) 2009-09-16 2015-06-16 Vaxart, Inc. Immunization strategy to prevent H1N1 infection
EP2478009B1 (en) 2009-09-17 2016-06-01 Ramot at Tel-Aviv University Ltd. Peptides for the treatment of oxidative stress related disorders
WO2011033506A3 (en) 2009-09-17 2011-09-29 Yeda Research And Development Co. Ltd. Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
US8735124B2 (en) 2009-09-17 2014-05-27 Yeda Research And Development Co. Ltd. Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
CA2775092A1 (en) 2009-09-23 2011-03-31 Protiva Biotherapeutics, Inc. Compositions and methods for silencing genes expressed in cancer
US20130023433A1 (en) 2009-09-28 2013-01-24 Yuling Luo Methods of detecting nucleic acid sequences with high specificity
US20110076232A1 (en) 2009-09-29 2011-03-31 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
WO2011040973A3 (en) 2009-10-02 2011-11-24 Ludwig Institute For Cancer Research Ltd. Tnf-immunoconjugates with fibroblast activation protein antibodies and methods and uses thereof
JP2013506664A (en) 2009-10-02 2013-02-28 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ リミテッド Anti fibroblast activation protein antibodies and methods and uses thereof
US20110081706A1 (en) * 2009-10-02 2011-04-07 TransAlgae Ltd Method and system for efficient harvesting of microalgae and cyanobacteria
US20120252742A1 (en) 2009-10-06 2012-10-04 Kranz David M Human Single-Chain T Cell Receptors
WO2011044553A1 (en) 2009-10-11 2011-04-14 Biogen Idec Ma Inc. Anti-vla-4 related assays
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
CN105368836A (en) 2009-10-14 2016-03-02 耶路撒冷希伯来大学伊森姆研究发展公司 Compositions for controlling varroa mites in bees
ES2609006T3 (en) 2009-10-16 2017-04-18 Rutgers, The State University Of New Jersey Procedimeinto treatment chronically injured nerve tissue using a cell therapy strategy
WO2011048600A9 (en) 2009-10-21 2011-08-18 Danziger Innovations Ltd. Generating genotypic variations in plant genomes by gamete infection
WO2011056688A3 (en) 2009-10-27 2011-10-06 Caris Life Sciences, Inc. Molecular profiling for personalized medicine
WO2011058555A1 (en) 2009-11-12 2011-05-19 Yeda Research And Development Co. Ltd. A method of editing dna in a cell and constructs capable of same
WO2011058557A1 (en) 2009-11-12 2011-05-19 Ramot At Tel-Aviv University Ltd. Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
US9260517B2 (en) 2009-11-17 2016-02-16 Musc Foundation For Research Development Human monoclonal antibodies to human nucleolin
WO2011061736A1 (en) 2009-11-17 2011-05-26 Protalix Ltd. Alkaline alpha galactosidase for the treatment of fabry disease
GB0920089D0 (en) 2009-11-17 2009-12-30 Danisco Method
US8592151B2 (en) * 2009-11-17 2013-11-26 Musc Foundation For Research Development Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
EP2504472A1 (en) 2009-11-24 2012-10-03 Collplant Ltd. Method of generating collagen fibers
CN105112357A (en) 2009-11-30 2015-12-02 普拉里斯坦有限公司 Adherent cells from placenta and use of same in disease treatment
US8835120B2 (en) 2009-12-02 2014-09-16 Abbott Laboratories Assay for cardiac troponin-T (cTnT)
US8652788B2 (en) * 2009-12-02 2014-02-18 Abbott Laboratories Assay for diagnosis of cardiac myocyte damage
US20110136141A1 (en) 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
US8183002B2 (en) 2009-12-03 2012-05-22 Abbott Laboratories Autoantibody enhanced immunoassays and kits
WO2011067745A3 (en) 2009-12-06 2011-08-04 Rosetta Green Ltd. Compositions and methods for enhancing plants resistance to abiotic stress
EP2510098B1 (en) 2009-12-09 2015-02-11 Quark Pharmaceuticals, Inc. Methods and compositions for treating diseases, disorders or injury of the cns
EP2513308B1 (en) 2009-12-17 2017-01-18 Merck Sharp & Dohme Corp. Modulation of pilr to treat immune disorders
GB0922377D0 (en) 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
CN102781449A (en) 2009-12-29 2012-11-14 加米达细胞有限公司 Methods for enhancing natural killer cell proliferation and activity
US9005579B2 (en) 2010-01-05 2015-04-14 Contrafect Corporation Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
US9316641B2 (en) 2010-01-11 2016-04-19 Biogen Ma Inc. Assay for JC virus antibodies
US20130052165A1 (en) 2010-01-12 2013-02-28 Livnat Bangio Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby
CN102822202B (en) 2010-01-27 2015-07-22 耶达研究及发展有限公司 Antibodies that inhibit metalloproteins
WO2011094669A1 (en) 2010-01-29 2011-08-04 Advanced Cell Diagnostics, Inc. Methods of in situ detection of nucleic acids
US8574832B2 (en) * 2010-02-03 2013-11-05 Massachusetts Institute Of Technology Methods for preparing sequencing libraries
KR20130008021A (en) 2010-02-04 2013-01-21 길리아드 바이오로직스, 인크. Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
ES2668645T3 (en) 2010-02-08 2018-05-21 Agensys Inc Antibody drug conjugates (ADC) that bind to 161P2F10B proteins
US9410131B2 (en) 2010-02-11 2016-08-09 Yeda Research And Development Co. Ltd. Enzymatic systems for carbon fixation and methods of generating same
WO2011104708A3 (en) 2010-02-24 2011-11-10 Ben Gurion University Of The Negev Research And Development Authority Methods for inhibiting necrosis
WO2011107939A1 (en) 2010-03-01 2011-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
US9732333B2 (en) 2011-01-20 2017-08-15 Protalix Ltd. Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
WO2011107994A1 (en) 2010-03-04 2011-09-09 Yeda Research And Development Co. Ltd. Methods of measuring protein stability
EP2545176B1 (en) 2010-03-08 2016-05-11 Yeda Research and Development Co. Ltd. Recombinant protein production in heterologous systems
WO2011111050A3 (en) 2010-03-11 2011-11-10 Jacob Edrei Methods of generating hydrogen
WO2011114251A1 (en) 2010-03-18 2011-09-22 Danisco A/S Foodstuff
US9073990B2 (en) 2010-04-05 2015-07-07 Bar-Llan University Protease-activatable pore-forming polypeptides
US9125931B2 (en) 2010-04-06 2015-09-08 Massachusetts Institute Of Technology Post-transcriptional regulation of RNA-related processes using encoded protein-binding RNA aptamers
US8927274B2 (en) 2010-04-12 2015-01-06 Technion Research & Development Foundation Limited Populations of pancreatic progenitor cells and methods of isolating and using same
WO2011128895A3 (en) 2010-04-12 2011-12-29 Ben Gurion University Of The Negev Research And Development Authority Sulfotransferase of a red microalga and uses thereof
WO2011129382A1 (en) 2010-04-16 2011-10-20 Abbott Japan Co. Ltd. Methods and reagents for diagnosing rheumatoid arthritis
WO2011132182A9 (en) 2010-04-18 2011-12-29 Yeda Research And Development Co. Ltd. MOLECULES AND METHODS OF USING SAME FOR TREATING ErbB/ErbB LIGANDS ASSOCIATED DISEASES
US20130053277A1 (en) 2010-05-04 2013-02-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods of identifying inhibitors of polypeptides-of-interest
WO2011138785A3 (en) 2010-05-05 2011-12-29 Rappaport Family Institute For Research In The Medical Sciences Use of ccl1 in therapy
EP2567232A1 (en) 2010-05-07 2013-03-13 AbbVie Inc. Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
US20120190563A1 (en) 2010-05-07 2012-07-26 Abbott Laboratories Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
ES2672918T3 (en) 2010-05-13 2018-06-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Isolated populations of adult kidney cells, and methods for isolating and using the same
EP2572197A4 (en) 2010-05-18 2013-08-28 Texas A & M Univ Sys Method and composition for the diagnosis and monitoring of inflammatory diseases
EP2576622A4 (en) 2010-06-01 2013-11-27 Univ Monash ANTIBODIES DIRECTED TO THE UNPROCESSED RECEPTOR TYROSINE KINASE c-MET
WO2011151833A1 (en) 2010-06-03 2011-12-08 Ramot At Tel-Aviv University Ltd. Methods of treating diabetes and compositions capable of same
EP2576829A1 (en) 2010-06-07 2013-04-10 Osnat Ashur-Fabian Methods and kits for diagnosing conditions related to hypoxia
US20130097731A1 (en) 2010-06-16 2013-04-18 Futuragene Israel Ltd. Pest-resistant plants containing a combination of a spider toxin and a chitinase
WO2011158243A3 (en) 2010-06-16 2012-04-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method of diagnosing and treating cancer
WO2012006056A3 (en) 2010-06-29 2012-04-05 Oregon Health & Science University Ccr6 as a biomarker of alzheimer's disease
GB201011513D0 (en) 2010-07-08 2010-08-25 Danisco Method
EP2407242A1 (en) 2010-07-13 2012-01-18 Dublin City University Direct clone analysis and selection technology
CA2805479A1 (en) 2010-07-15 2012-01-19 Technion Research & Development Foundation Ltd. Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides
CA2805478A1 (en) 2010-07-15 2012-01-19 Technion Research & Development Foundation Ltd. Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
CA2804728A1 (en) 2010-07-15 2012-01-19 Technion Research & Development Foundation Ltd. Nucleic acid construct for increasing abiotic stress tolerance in plants
WO2012009627A3 (en) 2010-07-16 2012-04-19 Vanderbilt University Low resource processor using surface tension valves for extracting, concentrating and detecting molecular species
US9624469B2 (en) 2010-07-22 2017-04-18 Cellect Biotherapeutics Ltd. Regulatory immune cells with enhanced targeted cell death effect
US9120862B2 (en) 2010-07-26 2015-09-01 Abbott Laboratories Antibodies relating to PIVKA-II and uses thereof
WO2012014205A1 (en) 2010-07-27 2012-02-02 Technion Research & Development Foundation Ltd. Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
JP2013535966A (en) 2010-07-27 2013-09-19 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド The method of generating induced pluripotent stem cells from hair follicle-derived keratinocytes withdrawn
US20130130311A1 (en) 2010-07-27 2013-05-23 Yeda Research And Development Co., Ltd. Methods and systems for assessing clonality of cell cultures
US8901074B2 (en) 2010-08-04 2014-12-02 Ramot At Tel-Aviv University Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
EP2606122A1 (en) 2010-08-22 2013-06-26 Ramot at Tel Aviv University, Ltd. Induced pluripotent stem cells derived from human pancreatic beta cells
WO2012025925A1 (en) 2010-08-24 2012-03-01 Rappaport Family Institute For Research In The Medical Sciences Methods of improving transplantation using sdf-1alpha
WO2012032519A3 (en) 2010-09-07 2012-07-05 Hadasit Medical Research Services And Development Ltd. Methods of diagnosing parkinson's disease
US20130236961A1 (en) 2010-09-07 2013-09-12 Technion Research & Development Foundation Limited Novel methods and culture media for culturing pluripotent stem cells
WO2012032510A1 (en) 2010-09-07 2012-03-15 Yeda Research And Development Co. Ltd. Primers for amplifying dna and methods of selecting same
WO2012032520A1 (en) 2010-09-07 2012-03-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
CN105907713A (en) 2010-09-08 2016-08-31 耶达研究及发展有限公司 Use Of Anti Third Party Central Memory T Cells For Anti-Leukemia/Lymphoma Treatment
WO2012032525A3 (en) 2010-09-08 2012-08-09 Yeda Research And Development Co. Ltd. An immunosuppressive drug combination for a stable and long term engraftment
EP2616539A1 (en) 2010-09-15 2013-07-24 Ramot at Tel-Aviv University Ltd. Methods of expanding and redifferentiating islet beta cells
WO2012038956A1 (en) 2010-09-20 2012-03-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method of treating neurodegenerative diseases
EP2441520A1 (en) 2010-10-12 2012-04-18 Eppendorf AG Real-time amplification and micro-array based detection of nucleic acid targets in a flow chip assay
US8951983B2 (en) 2010-10-17 2015-02-10 Yeda Research And Development Co. Ltd. Methods and compositions for the treatment of insulin-associated medical conditions
WO2012052878A1 (en) 2010-10-19 2012-04-26 Vascular Biogenics Ltd. Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
EP3034625B1 (en) 2010-10-21 2017-10-04 Advanced Cell Diagnostics, Inc. An ultra sensitive method for in situ detection of nucleic acids
WO2012056452A3 (en) 2010-10-27 2012-08-09 Nanocyte (Israel) Ltd. Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
US10066024B2 (en) 2010-10-28 2018-09-04 Yeda Research And Development Co. Ltd. Methods of generating antibodies to metalloenzymes
EP2635105B1 (en) 2010-11-04 2017-12-20 Ben-Gurion University of The Negev Research and Development Authority Acyl-coa: diacylglycerol acyltransferase 1-like gene (ptdgat1) and uses thereof
EP2640404B1 (en) 2010-11-17 2017-02-22 Ben Gurion University of The Negev Research and Development Authority T-cell therapy to neurodegenerative diseases
WO2012073238A1 (en) 2010-12-02 2012-06-07 Technion Research & Development Foundation Ltd. Methods of generating corneal cells and cell populations comprising same
US20120183960A1 (en) 2010-12-07 2012-07-19 Enterologics, Inc. Method for identifying e. coli m-17
EP2652125B1 (en) 2010-12-15 2017-04-26 Kadimastem Ltd. Insulin producing cells derived from pluripotent stem cells
CN107648341A (en) 2010-12-28 2018-02-02 卡梅迪斯有限公司 Plant extracts for the treatment and prevention of infections
DK2665833T3 (en) 2011-01-17 2017-07-24 Life Technologies Corp Working procedure for the detection of ligands using nucleic acids
WO2012103414A3 (en) 2011-01-28 2012-10-11 Advanced Cell Diagnostics, Inc. Rnascope® hpv assay for determining hpv status in head and neck cancers and cervical lesions
WO2012104851A9 (en) 2011-01-31 2012-09-13 Yeda Research And Development Co. Ltd. Methods of diagnosing disease using overlap extension pcr
JP5804395B2 (en) 2011-02-03 2015-11-04 ポップ テスト オンコロジー エルエルシー Systems and methods for diagnosis and treatment
WO2012109133A1 (en) 2011-02-07 2012-08-16 Research Development Foundation Engineered immunoglobulin fc polypeptides
WO2012114339A1 (en) 2011-02-23 2012-08-30 Rappaport Family Institute For Research In The Medical Sciences High affinity molecules capable of binding a type a plexin receptor and uses of same
US9212258B2 (en) 2011-02-23 2015-12-15 The Board Of Trustees Of The University Of Illinois Amphiphilic dendron-coils, micelles thereof and uses
WO2012117373A1 (en) 2011-03-03 2012-09-07 Ramot At Tel-Aviv University Ltd. Genetically modified muscle cells which express neurotrophic factors
EP2683821B1 (en) 2011-03-06 2018-07-25 Merck Serono SA Low fucose cell lines and uses thereof
WO2012120518A1 (en) 2011-03-08 2012-09-13 Ramot At Tel-Aviv University Ltd. Compositions and methods for diagnosing and treating phenylketonuria (pku)
US9057107B2 (en) 2011-03-08 2015-06-16 King Abdullah University Of Science And Technology Molecular biomarker set for early detection of ovarian cancer
US20140170068A1 (en) 2011-03-11 2014-06-19 Board Of Regents Of The University Of Nebraska Biomarker for coronary artery disease
US20140086839A1 (en) 2011-03-17 2014-03-27 Tel Hashomer Medical Research Infrastructure And Services Ltd. Quinolone analogs for treating autoimmune diseases
CN103429619B (en) 2011-03-17 2017-07-28 雷蒙特亚特特拉维夫大学有限公司 Bispecific and monospecific antibodies and methods for preparing asymmetric
WO2012129378A1 (en) 2011-03-22 2012-09-27 Keutgen Xavier M Distinguishing benign and malignant indeterminate thyroid lesions
WO2012131680A3 (en) 2011-03-28 2013-01-24 Yeda Research And Development Co. Ltd. Compositions and methods for treating inflammation based on inhibiting cd151 activity
WO2012131594A1 (en) 2011-03-28 2012-10-04 Novartis Ag Markers associated with cyclin-dependent kinase inhibitors
KR20140027969A (en) 2011-04-01 2014-03-07 이뮤노젠 아이엔씨 Methods for increasing efficacy of folr1 cancer therapy
DK2694095T3 (en) 2011-04-05 2018-05-28 Longevity Biotech Inc Compositions comprising glucagon analogs and methods for making and using the same
WO2012137202A1 (en) 2011-04-05 2012-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
WO2012142164A1 (en) 2011-04-12 2012-10-18 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
EP2699253B1 (en) 2011-04-21 2018-03-28 The Rockefeller University Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
WO2012150600A2 (en) 2011-05-04 2012-11-08 Ramot At Tel-Aviv University Ltd. Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
WO2012153333A1 (en) 2011-05-09 2012-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Regeneration and repair of mesenchymal tissue using amelogenin
WO2012153336A3 (en) 2011-05-12 2013-11-21 Rakuto Bio Technologies Ltd. Methods and device for lightening skin complexion
WO2012156976A8 (en) 2011-05-16 2013-02-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods of producing artemisinin in non-host plants and vectors for use in same
CN103620409B (en) 2011-05-20 2017-04-12 阿波特日本有限公司 Immunoassay method for reducing non-specific binding reagent and
JP2014522237A (en) 2011-05-20 2014-09-04 オリゴメリックス インコーポレイテッド Tau protease compositions and methods of use
US20140088017A1 (en) 2011-05-23 2014-03-27 Yeda Research And Development Co., Ltd. Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
WO2012160526A3 (en) 2011-05-23 2013-03-14 Ofir Menashe Water treatment methods involving particles
CN107325164A (en) 2011-05-31 2017-11-07 和黄生物膜医疗解决方案有限公司 Dispersion and detachment of cell aggregates
US20140113376A1 (en) 2011-06-01 2014-04-24 Rotem Sorek Compositions and methods for downregulating prokaryotic genes
JP6141834B2 (en) 2011-06-06 2017-06-07 ノヴォ ノルディスク アー/エス Therapeutic antibody
ES2670596T3 (en) 2011-06-14 2018-05-31 Yeda Research And Development Co. Ltd. Combination therapy to prevent the formation and progression of DCIS to breast cancer
WO2013010170A1 (en) 2011-07-14 2013-01-17 Lovell Mark A Process for detection of alzheimer's disease from a serum sample
JP2014523914A (en) 2011-07-18 2014-09-18 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Engineered microbe targeting molecules and uses thereof
WO2013011507A1 (en) 2011-07-20 2013-01-24 Kaiima Bio Agritech Ltd. Maize plants having a partially or fully multiplied genome and uses thereof
US20130030452A1 (en) 2011-07-27 2013-01-31 Health Corporation - Rambam Devices for surgical applications
CN104039960B (en) 2011-08-04 2017-05-10 耶达研究及发展有限公司 The compositions and corticotropin-releasing hormone related disorders micro rna rna containing a micro - and for the treatment and diagnosis of serotonin -, - adrenergic, norepinephrine - glutamic acid
EP2739310B1 (en) 2011-08-05 2018-04-18 Research Development Foundation Improved methods and compositions for modulation of olfml3 mediated angiogenesis
EP2741753A2 (en) 2011-08-09 2014-06-18 Yeda Research and Development Co. Ltd. Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
RU2014108930A (en) 2011-08-14 2015-09-20 Каиима Био Агритех Лтд. Durum wheat plants having completely or partially multiplied genome and their applications
ES2657552T3 (en) 2011-09-08 2018-03-05 Yeda Research And Development Co. Ltd. New biomarkers of risk for lung cancer
CN103957697B (en) 2011-09-13 2017-10-24 孟山都技术公司 A method for controlling weeds and compositions
US9840715B1 (en) 2011-09-13 2017-12-12 Monsanto Technology Llc Methods and compositions for delaying senescence and improving disease tolerance and yield in plants
CA2848680A1 (en) 2011-09-13 2013-03-21 Monsanto Technology Llc Methods and compositions for weed control
US9920326B1 (en) 2011-09-14 2018-03-20 Monsanto Technology Llc Methods and compositions for increasing invertase activity in plants
US9249467B2 (en) 2011-09-16 2016-02-02 Steven Goodison Bladder cancer detection composition, kit and associated methods
WO2013052643A1 (en) 2011-10-05 2013-04-11 The Rockefeller University Dimeric bacteriophage lysins
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
WO2013054320A1 (en) 2011-10-11 2013-04-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
JP2014530826A (en) 2011-10-21 2014-11-20 オ−グレックス ライフ サイエンシズ コーポレイション Antigen from citrullinated 14-3-3, and use thereof in the diagnosis of rheumatoid arthritis
EP2771464B1 (en) 2011-10-27 2018-03-21 Yeda Research and Development Co. Ltd. Methods of treating cancer
WO2013064163A1 (en) 2011-11-01 2013-05-10 Academisch Medisch Centrum Methylation markers for colorectal cancer
US20140323549A1 (en) 2011-11-08 2014-10-30 Quark Pharmaceuticals, Inc. Methods and compositions for treating diseases, disorders or injury of the nervous system
US9736998B2 (en) 2011-11-23 2017-08-22 Danziger Dan Flower Farm Otomeria plants
US9617331B2 (en) 2011-11-27 2017-04-11 Yeda Research And Development Co. Ltd. Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
RU2014127338A (en) 2011-12-08 2016-02-10 Иеда Рисерч Энд Девелопмент Ко., Лтд. Embryonic lung cells of mammals and their therapeutic use
CA2859167A1 (en) 2011-12-12 2013-06-20 Step Ahead Innovations, Inc. Aquatic environment monitoring and dosing systems and apparatuses, and methods and software relating thereto
WO2013093921A1 (en) 2011-12-20 2013-06-27 Collplant Ltd. Collagen coated synthetic polymer fibers
US20130164193A1 (en) 2011-12-22 2013-06-27 Life Technologies Corporation Sequential lateral flow capillary device for analyte determination
US9035039B2 (en) 2011-12-22 2015-05-19 Protiva Biotherapeutics, Inc. Compositions and methods for silencing SMAD4
US20140348818A1 (en) 2011-12-29 2014-11-27 Baylor Research Institute Biomarkers of kawasaki disease
CN104080480A (en) 2012-01-01 2014-10-01 奇比艾企业有限公司 Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
WO2013114363A3 (en) 2012-01-30 2013-11-28 Yeda Research And Development Co. Ltd. Antimicrobial agents
US9603907B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Dry powder formulations of dNase I
US10047345B2 (en) 2012-02-13 2018-08-14 Gamida-Cell Ltd. Culturing of mesenchymal stem cells with FGF4 and nicotinamide
US20150023929A1 (en) 2012-02-19 2015-01-22 Protalix Ltd. Oral unit dosage forms and uses of same for the treatment of gaucher disease
WO2013124817A3 (en) 2012-02-22 2014-01-03 Brainstem Biotec Ltd. MicroRNAS FOR THE GENERATION OF ASTROCYTES
WO2013124816A3 (en) 2012-02-22 2014-01-03 Brainstem Biotec Ltd. Generation of neural stem cells and motor neurons
JP6249966B2 (en) 2012-02-29 2017-12-20 ケモセントリックス, インコーポレイテッド Aza - aryl 1h- pyrazol-1-yl benzenesulfonamide
EP2833714A1 (en) 2012-03-01 2015-02-11 The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
EP2822971B1 (en) 2012-03-07 2018-07-18 Yeda Research and Development Co. Ltd. Compositions for inhibition of quiescin sulfhydryl oxidase (qsox1) and uses of same
WO2013140389A1 (en) 2012-03-22 2013-09-26 Ramot At Tel-Aviv University Ltd. Plif multimeric peptides and uses thereof
CA2868883A1 (en) 2012-03-30 2013-10-03 Sorrento Therapeutics Inc. Fully human antibodies that bind to vegfr2
US20140178869A1 (en) 2012-04-05 2014-06-26 Advanced Cell Diagnostics, Inc. Detection of immunoglobulin light chain restriction by rna in situ hybridization
EP2839015A4 (en) 2012-04-18 2015-08-26 Univ Ramot Lipidated glycosaminoglycan particles for the delivery of nucleic acids
KR20150008137A (en) 2012-04-19 2015-01-21 옵코 바이오로직스 리미티드 Long-acting oxyntomodulin variants and methods of producing same
US20130280696A1 (en) 2012-04-23 2013-10-24 Elliott Millenson Devices and methods for detecting analyte in bodily fluid
WO2013160895A1 (en) 2012-04-24 2013-10-31 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
EP2846819B1 (en) 2012-05-09 2017-05-03 Yeda Research and Development Co. Ltd. Variants of tace pro-domain as tnf-a inhibitor and their medical use
CN108690132A (en) 2012-05-10 2018-10-23 生物蛋白有限公司 Multi-specific monoclonal antibodies
US8865158B2 (en) 2012-05-22 2014-10-21 Ramot At Tel-Aviv University Ltd. Bacteriophages for reducing toxicity of bacteria
CN104619843A (en) 2012-05-24 2015-05-13 A.B.种子有限公司 Compositions and methods for silencing gene expression
WO2013174003A1 (en) 2012-05-24 2013-11-28 Mountgate Group Limited Compositions and methods related to prevention and treatment of rabies infection
WO2013183048A1 (en) 2012-06-03 2013-12-12 Ben-Gurion University Of The Negev Research And Development Authority Functionalized titanium binding peptides and implants coated with same
KR20150021087A (en) 2012-06-04 2015-02-27 옵코 바이오로직스 리미티드 Pegylated oxm variants
CA2875710A1 (en) 2012-06-22 2013-12-27 John Wayne Cancer Institute Molecular malignancy in melanocytic lesions
WO2014006621A1 (en) 2012-07-03 2014-01-09 Nanospun Technologies Ltd. Methods and devices for adsorption and biodegradation of petroleum
US9910040B2 (en) 2012-07-09 2018-03-06 Sevident, Inc. Molecular nets comprising capture agents and linking agents
US9733242B2 (en) 2012-10-07 2017-08-15 Sevident, Inc. Devices for capturing analyte
WO2014011398A1 (en) 2012-07-09 2014-01-16 Novartis Ag Biomarkers associated with cdk inhibitors
EP3327090A1 (en) 2012-07-18 2018-05-30 President and Fellows of Harvard College Modification of surfaces for simulataneous repellency and targeted binding of desired moieties
WO2014018375A1 (en) 2012-07-23 2014-01-30 Xenon Pharmaceuticals Inc. Cyp8b1 and uses thereof in therapeutic and diagnostic methods
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
WO2014020599A1 (en) 2012-07-29 2014-02-06 Yeda Research And Development Co. Ltd. Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms
US9371568B2 (en) 2012-07-31 2016-06-21 Novartis Ag Markers associated with human double minute 2 inhibitors
CN104684558A (en) 2012-07-31 2015-06-03 耶达研究及发展有限公司 Methods of diagnosing and treating motor neuron diseases
CA2877223A1 (en) 2012-08-06 2014-02-13 Brainstorm Cell Therapeutics Ltd. Methods of generating mesenchymal stem cells which secrete neurotrophic factors
US20140068814A1 (en) 2012-09-03 2014-03-06 A.B. Seeds Ltd. Method of improving abiotic stress tolerance of plants and plants generated thereby
EP2895197A1 (en) 2012-09-12 2015-07-22 Ramot at Tel-Aviv University Ltd. Immunoparticles and methods of generating and using same
WO2014057490A1 (en) 2012-10-09 2014-04-17 Ramot At Tel-Aviv University Ltd. Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
US9650436B2 (en) 2012-10-12 2017-05-16 Arizona Board Of Regents On Behalf Of Arizona State University Antibody based reagents that specifically recognize toxic oligomeric forms of tau
US9395369B2 (en) 2012-10-19 2016-07-19 Regents Of The University Of Minnesota Guinea pig cytomegalovirus (CIDMTR strain)
EP2909230A1 (en) 2012-10-19 2015-08-26 Danisco US Inc. Stabilization of biomimetic membranes
WO2014062635A1 (en) 2012-10-19 2014-04-24 Novartis Ag Markers for acute lymphoblastic leukemia
EP2912064A1 (en) 2012-10-24 2015-09-02 Research Development Foundation Jam-c antibodies and methods for treatment of cancer
US20150266970A1 (en) 2012-10-24 2015-09-24 Yeda Research And Development Co. Ltd. Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
US9926564B2 (en) 2012-10-29 2018-03-27 Yeda Research And Development Co. Ltd. Aptamers, multimeric aptamers and uses thereof
EP3074044A2 (en) 2013-11-28 2016-10-05 Yeda Research and Development Co., Ltd. Synaptojanin-2 inhibitors and uses thereof
US20150290233A1 (en) 2012-11-29 2015-10-15 Yeda Research And Development Co.Ltd. At The Weizmann Institute Of Science Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
US10047399B2 (en) 2013-01-07 2018-08-14 The Cleveland Clinic Foundation ABCA1 downregulation in prostate cancer
WO2014108850A3 (en) 2013-01-09 2014-11-27 Yeda Research And Development Co. Ltd. High throughput transcriptome analysis
WO2014108854A1 (en) 2013-01-09 2014-07-17 Fusimab Ltd. Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
WO2014111936A1 (en) 2013-01-17 2014-07-24 Novellusdx Ltd. Methods and systems for identifying patient specific driver mutations
US10000767B2 (en) 2013-01-28 2018-06-19 Monsanto Technology Llc Methods and compositions for plant pest control
WO2014121091A1 (en) 2013-02-01 2014-08-07 The Regents Of The University Of California Methods for genome assembly and haplotype phasing
EP2951290B1 (en) 2013-02-01 2017-11-29 The United States of America, as represented by The Secretary, Department of Health and Human Services Method for generating retinal pigment epithelium (rpe) cells from induced pluripotent stem cells (ipscs)
US9411930B2 (en) 2013-02-01 2016-08-09 The Regents Of The University Of California Methods for genome assembly and haplotype phasing
CA2904035A1 (en) 2013-03-06 2014-09-12 Protalix Ltd. Tnf alpha inhibitor polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
CA2902727A1 (en) 2013-03-06 2014-09-12 Protalix Ltd. Use of plant cells expressing a tnfalpha polypeptide inhibitor in therapy
WO2014159242A1 (en) 2013-03-14 2014-10-02 Novartis Ag Notch 3 mutants and uses thereof
CN105246916A (en) 2013-03-14 2016-01-13 诺华股份有限公司 Antibodies against notch 3
US9273349B2 (en) 2013-03-14 2016-03-01 Affymetrix, Inc. Detection of nucleic acids
US20140273031A1 (en) 2013-03-15 2014-09-18 The Cleveland Clinic Foundation In-vitro method for monoclonal antibody production
EP2976097A1 (en) 2013-03-21 2016-01-27 CollPlant Ltd. Compositions comprising collagen and prp for tissue regeneration
KR20150135432A (en) 2013-03-24 2015-12-02 바이오카인 테라퓨틱스 리미티드 Methods of treating myeloid leukemia
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP2988767A1 (en) 2013-04-21 2016-03-02 Yeda Research and Development Co., Ltd. Agents for downregulation of the activity and/or amount of bcl-xl and/or bcl-w
US20140315301A1 (en) 2013-04-23 2014-10-23 Yeda Research And Development Co. Ltd. Isolated naive pluripotent stem cells and methods of generating same
WO2014176047A1 (en) 2013-04-25 2014-10-30 Novartis Ag Markers for ezh2 inhibitors
US9714268B2 (en) 2013-04-25 2017-07-25 Yeda Research And Development Co. Ltd. Use of inhibitory peptides for the treatment of inflammatory diseases
EP2999717B1 (en) 2013-05-21 2018-08-08 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Treatment of mast cell related pathologies
EP3010519A1 (en) 2013-06-18 2016-04-27 Dnatrix Inc. Treatment of brain cancer with oncolytic adenovirus
US9784686B2 (en) 2013-06-19 2017-10-10 Step Ahead Innovations, Inc. Aquatic environment water parameter testing systems and methods
EP3013380A1 (en) 2013-06-24 2016-05-04 Ramot at Tel-Aviv University Ltd. Omentum based scaffold and delivery system
WO2015010026A3 (en) 2013-07-19 2015-04-23 Monsanto Technology Llc Compositions and methods for controlling leptinotarsa
US9850496B2 (en) 2013-07-19 2017-12-26 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
WO2015015489A1 (en) 2013-07-30 2015-02-05 Biolinerx Ltd. Antibody for treating diabetes and autoimmune diseases
WO2015017552A1 (en) 2013-08-01 2015-02-05 Agensys, Inc. Antibody drug conjugates (adc) that bind to cd37 proteins
WO2015029035A8 (en) 2013-08-29 2015-08-06 Yeda Research And Development Co. Ltd. SELECTIVE INHIBITORS OF α2 ISOFORM OF Na,K-ATPase AND USE FOR REDUCTION OF INTRA-OCULAR PRESSURE
WO2015033343A1 (en) 2013-09-03 2015-03-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for expressing recombinant polypeptides
WO2015033344A1 (en) 2013-09-05 2015-03-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
WO2015037009A8 (en) 2013-09-16 2015-05-14 Plexicure Ltd. Isolated proteins capable of binding plexin-a4 and methods of producing and using same
EP3046929A4 (en) 2013-09-17 2017-02-08 Yeda Research and Development Co., Ltd. Erk-derived peptides and uses thereof
US9476884B2 (en) 2013-10-04 2016-10-25 University Of Massachusetts Hybridization- independent labeling of repetitive DNA sequence in human chromosomes
WO2015059690A8 (en) 2013-10-24 2015-07-23 Yeda Research And Development Co. Ltd. Polynucleotides encoding brex system polypeptides and methods of using same
WO2015063768A8 (en) 2013-10-31 2015-06-25 Biokine Therapeutics Ltd. Methods of treating acute myeloid leukemia with a flt3 mutation
US9982229B2 (en) 2013-12-19 2018-05-29 Danisco Us Inc. Use of hydrophobins to increase gas transfer in aerobic fermentation processes
CA2935577A1 (en) 2014-01-07 2015-07-16 Bioatla, Llc Proteins targeting orthologs
CN106132992A (en) 2014-01-29 2016-11-16 达娜-法勃肿瘤研究所公司 Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)
WO2015114633A8 (en) 2014-01-30 2015-11-26 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
US20170042893A1 (en) 2014-02-03 2017-02-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Use of casein kinase i inhibitors for depleting stem cells
CN106715695A (en) 2014-02-05 2017-05-24 耶达研究及发展有限公司 Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
US10066014B2 (en) 2014-02-06 2018-09-04 Yeda Research And Development Co. Ltd. Anti CD84 antibodies, compositions comprising same and uses thereof
US20150247204A1 (en) 2014-02-07 2015-09-03 The General Hopital Corporation Differential diagnosis of hepatic neoplasms
WO2015118547A1 (en) 2014-02-10 2015-08-13 Protalix Ltd. Method of maintaining disease stability in a subject having gaucher's disease
US20160334392A1 (en) 2014-02-11 2016-11-17 Brain Storm Cell Therapeutics Ltd. Method of qualifying cells
US20150232935A1 (en) 2014-02-14 2015-08-20 The General Hospital Corporation Methods for diagnosing igg4-related disease
WO2015131099A1 (en) 2014-02-28 2015-09-03 The General Hospital Corporation Diagnosis of multiple myeloma and lymphoma
US20170067894A1 (en) 2014-03-03 2017-03-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method and device for detection of pseudomonas aeruginosa
EP2923709A1 (en) 2014-03-28 2015-09-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Multi-component-multistage malaria vaccine
CN106574296A (en) 2014-04-14 2017-04-19 耶路撒冷希伯来大学伊森姆研究发展公司 A method and kit for determining the tissue or cell origin of DNA
WO2015159295A1 (en) 2014-04-17 2015-10-22 Yeda Research And Development Co. Ltd. Methods and kits for analyzing dna binding moieties attached to dna
CN106460048A (en) 2014-04-28 2017-02-22 耶达研究及发展有限公司 Microbiome response to agents
US20170191065A1 (en) 2014-05-04 2017-07-06 Forrest Innovations Ltd. Compositions and methods of using same for increasing resistance of infected mosquitoes
EP2942627A1 (en) 2014-05-05 2015-11-11 MicroBPlex, Inc. Media elaborated with newly synthesized antibodies (mensa) from recently proliferated antibody secreting cells (asc) and uses thereof
WO2015179435A1 (en) 2014-05-19 2015-11-26 Bayer Healthcare Llc Optimized humanized monoclonal antibodies against activated protein c and uses thereof
EP3145947A2 (en) 2014-05-22 2017-03-29 Yeda Research and Development Co., Ltd. Recombinant microorganisms capable of carbon fixation
WO2015186129A1 (en) 2014-06-02 2015-12-10 Technion Research & Development Foundation Limited. Compositions and methods of selectively inhibiting irp1 and treating inflammation
US20170183376A1 (en) 2014-06-24 2017-06-29 Insight Biopharmaceuticals Ltd. Methods of purifying antibodies
US20170199195A1 (en) 2014-06-25 2017-07-13 Tel Hashomer Medical Research Infrastructure And Services Ltd. Identification of cancer stem cells markers and use of same for diagnosis and treatment
WO2016005985A3 (en) 2014-07-09 2016-03-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method for reprogramming cells
RU2017104284A (en) 2014-07-15 2018-08-15 Йиссум Рисеч Девелопмент Компани Оф Зе Хебрю Юниверсити Оф Джерусалем Лтд. Cd44 isolated polypeptides and their use
US20170275593A1 (en) 2014-07-30 2017-09-28 Yeda Research And Development Co. Ltd. Media for culturing pluripotent stem cells
WO2016030899A8 (en) 2014-08-28 2016-03-24 Yeda Research And Development Co. Ltd. Methods of treating amyotrophic lateral scleroses
EP3176183A1 (en) 2015-12-02 2017-06-07 Yeda Research and Development Co. Ltd Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
CA2959716A1 (en) 2014-09-08 2016-03-17 Yeda Research And Development Co. Ltd. Anti-her3 antibodies and uses of same
EP2992895A1 (en) 2014-09-08 2016-03-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Three-component-multistage malaria vaccine
JP2017534574A (en) 2014-09-08 2017-11-24 イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. Compositions and methods for treating cancer resistant to tyrosine kinase inhibitors (tki)
WO2016038550A1 (en) 2014-09-11 2016-03-17 Novartis Ag Inhibition of prmt5 to treat mtap-deficiency-related diseases
EP3230453A2 (en) 2014-09-21 2017-10-18 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Downregulating mir-132 for the treatment of lipid related disorders
EP3207156A1 (en) 2014-10-13 2017-08-23 Life Technologies Corporation Methods, kits & compositions for determining gene copy numbers
CA2962956A1 (en) 2014-10-20 2016-04-28 Gen-Probe Incorporated Red blood cell lysis solution
WO2016062855A1 (en) 2014-10-24 2016-04-28 Dupont Nutrition Biosciences Aps Proline tolerant tripeptidyl peptidases and uses thereof
EP3221470A2 (en) 2014-11-17 2017-09-27 Yeda Research and Development Co., Ltd. Method of analyzing microbiome
WO2016079736A3 (en) 2014-11-17 2016-07-28 Yeda Research And Development Co. Ltd. Methods of treating diseases related to mitochondrial function
WO2016079739A9 (en) 2014-11-20 2017-02-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
WO2016089883A1 (en) 2014-12-01 2016-06-09 Novartis Ag Compositions and methods for diagnosis and treatment of prostate cancer
WO2016092555A3 (en) 2014-12-11 2016-09-01 Yeda Research And Development Co. Ltd. Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
WO2016103269A8 (en) 2014-12-23 2016-08-25 Ramot At Tel-Aviv University Ltd. Populations of neural progenitor cells and methods of producing and using same
WO2016108240A1 (en) 2014-12-30 2016-07-07 Cell Cure Neurosciences Ltd. Assessing retinal pigment epithelial cell populations
US20180016553A1 (en) 2014-12-30 2018-01-18 Cell Cure Neurosciences Ltd. Rpe cell populations and methods of generating same
CN107406837A (en) 2015-01-04 2017-11-28 波塔力克斯有限公司 Modified dnase and uses thereof
WO2016116935A1 (en) 2015-01-21 2016-07-28 Yeda Research And Development Co. Ltd. Use of rasa2 as a prognostic and therapeutic marker for melanoma
JP2018505893A (en) 2015-02-09 2018-03-01 リサーチ ディベロップメント ファウンデーション Engineered immunoglobulin fc polypeptide shows improved complement activation
KR20170134379A (en) 2015-02-17 2017-12-06 더브테일 제노믹스 엘엘씨 Nucleic acid sequence assembly
WO2016135732A8 (en) 2015-02-26 2017-11-23 Yeda Research And Development Co. Ltd. Method of promoting hair growth
EP3268475A1 (en) 2015-03-11 2018-01-17 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Decoy oligonucleotides for the treatment of diseases
WO2016157190A1 (en) 2015-03-31 2016-10-06 Yeda Research And Development Co. Ltd. Glutamate oxaloacetate transaminase 1 (got1), preparations and methods of generating same and uses thereof
CN107690429A (en) 2015-04-07 2018-02-13 Ela制药有限公司 Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto
CN108135863A (en) 2015-04-27 2018-06-08 特拉维夫医疗中心医学研究基础设施和保健服务基金会 EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
WO2016174652A1 (en) 2015-04-30 2016-11-03 Technion Research & Development Foundation Limited Chimeric antigen receptors and methods of their use
WO2016182984A1 (en) 2015-05-08 2016-11-17 Centrillion Technology Holdings Corporation Disulfide-linked reversible terminators
WO2016181393A1 (en) 2015-05-11 2016-11-17 Yeda Research And Development Co. Ltd. Citrin inhibitors for the treatment of cancer
WO2016185457A1 (en) 2015-05-19 2016-11-24 Yeda Research And Development Co. Ltd. Methods of promoting lymphangiogenesis
US20180117173A1 (en) 2015-05-20 2018-05-03 Yeda Research And Development Co. Ltd. Method of targeting senescent cells
CA2986203A1 (en) 2015-05-21 2016-11-24 Yeda Research And Development Co. Ltd. Bacterial populations for promoting health
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
WO2016203476A1 (en) 2015-06-18 2016-12-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods and compositions for diagnosing and treating urothelial cancer
EP3310388A1 (en) 2015-06-18 2018-04-25 Yeda Research and Development Co., Ltd. Conditioning protocols and use of same for tissue regeneration
US20180291360A1 (en) 2015-06-26 2018-10-11 Dupont Nutrition Biosciences Aps Aminopeptidases for protein hydrolyzates
CN107921087A (en) 2015-07-16 2018-04-17 百欧肯治疗有限公司 Compositions and methods for treating cancer
EP3322424A1 (en) 2015-07-16 2018-05-23 Yeda Research and Development Co., Ltd. Use of anti third party central memory t cells
EP3324754A1 (en) 2015-07-22 2018-05-30 Phytopharma International Ltd. Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby
EP3328995A1 (en) 2015-07-29 2018-06-06 Hadasit Medical Research Services And Development Large scale production of retinal pigment epithelial cells
EP3331546A1 (en) 2015-08-03 2018-06-13 Biokine Therapeutics Ltd. Cxcr4 binding agents for treatment of diseases
WO2017021961A1 (en) 2015-08-04 2017-02-09 Yeda Research And Development Co. Ltd. Methods of screening for riboswitches and attenuators
CA2993912A1 (en) 2015-08-05 2017-02-09 Cell Cure Neurosciences Ltd. Preparation of retinal pigment epithelium cells
EP3331995A1 (en) 2015-08-05 2018-06-13 Cell Cure Neurosciences Ltd. Preparation of photoreceptors for the treatment of retinal diseases
WO2017025967A1 (en) 2015-08-13 2017-02-16 Forrest Innovations Ltd. Formulations and compositions for delivery of nucleic acids to plant cells
WO2017033188A1 (en) 2015-08-24 2017-03-02 Yeda Research And Development Co. Ltd. Algal oil and biofuel and methods of producing same
US20170192017A1 (en) 2015-08-25 2017-07-06 Prothena Biosciences Limited Methods For Detecting Phosphorylated Alpha-Synuclein
WO2017040380A3 (en) 2015-08-28 2017-04-20 Research Development Foundation Engineered antibody fc variants
WO2017042816A1 (en) 2015-09-10 2017-03-16 Yeda Research And Development Co. Ltd. Ablation of perforin positive dendritic cells in cancer treatment
CA3000405A1 (en) 2015-09-29 2017-04-06 Htg Molecular Diagnostics, Inc. Methods for subtyping diffuse b-cell lymphoma (dlbcl)
EP3365376A1 (en) 2015-10-25 2018-08-29 Yeda Research and Development Co., Ltd. Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
CN108699525A (en) 2015-10-26 2018-10-23 细胞治疗神经科学有限公司 Preparation of retinal pigment epithelial cells
CA3002767A1 (en) 2015-10-27 2017-05-04 Zvi VOGEL Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
EP3368058A1 (en) 2015-10-29 2018-09-05 Yeda Research and Development Co., Ltd. A method of inducing cardiomyocytes proliferation and treating heart diseases
WO2017077539A9 (en) 2015-11-03 2018-06-21 Ariel-University Research And Development Company Ltd. Compositions for regeneration and repair of neural tissue
WO2017118985A1 (en) 2016-01-06 2017-07-13 Yeda Research And Development Co. Ltd. Compositions and methods for treating malignant, autoimmune and inflammatory diseases
WO2017130205A1 (en) 2016-01-31 2017-08-03 Hadasit Medical Research Services And Development Ltd. Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
US10036011B2 (en) 2016-02-11 2018-07-31 Qiagen Waltham, Inc. Scavenger compounds for improved sequencing-by-synthesis
WO2017138008A3 (en) 2016-02-14 2017-11-02 Yeda Research And Development Co. Ltd. Methods of modulating protein exocytosis and uses of same in therapy
WO2017138007A8 (en) 2016-02-14 2018-08-16 Yeda Research And Development Co. Ltd. Microbiome-based diagnosis, prediction and treatment of relapsing obesity
WO2017141253A1 (en) 2016-02-16 2017-08-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Non-protein phenylalanine analogues for inhibiting cyanobacteria and plant growth
WO2017147186A1 (en) 2016-02-22 2017-08-31 Ursure, Inc. System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
CA3013383A1 (en) 2016-02-25 2017-08-31 Dupont Nutrition Biosciences Aps Method for producing a protein hydrolysate employing an aspergillus fumigatus tripeptidyl peptidase
WO2017153982A1 (en) 2016-03-06 2017-09-14 Yeda Research And Development Co. Ltd. Method for modulating myelination
CA3017608A1 (en) 2016-03-29 2017-10-05 Stcube, Inc. Dual function antibodies specific to glycosylated pd-l1 and methods of use thereof
WO2017189746A1 (en) 2016-04-27 2017-11-02 Gen-Probe Incorporated Blood cell lysis reagent
WO2017194589A1 (en) 2016-05-10 2017-11-16 Vib Vzw Inhibition of tau-mediated early synaptic dysfunction
WO2017201064A1 (en) 2016-05-16 2017-11-23 President And Fellows Of Harvard College Aqueous biomolecule coupling on co2-plasma-activated surfaces
WO2017203520A1 (en) 2016-05-22 2017-11-30 Yeda Research And Development Co. Ltd. Methods of using pulmonary cells for transplantation and induction of tolerance
WO2017208247A1 (en) 2016-06-02 2017-12-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Assay for the removal of methyl-cytosine residues from dna
WO2017212476A1 (en) 2016-06-05 2017-12-14 Tel Hashomer Medical Research Infrastructure And Services Ltd. Novel molecules for the treatment of inflammation
WO2017212494A1 (en) 2016-06-09 2017-12-14 Opko Biologics Ltd. Long-acting oxyntomodulin formulation and methods of producing and administering same
WO2017221225A1 (en) 2016-06-19 2017-12-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Screening for chemotherapy resistance in human haploid cells
WO2018002924A1 (en) 2016-06-27 2018-01-04 Yeda Research And Development Co. Ltd. Veto cells generated from memory t cells
WO2018001932A1 (en) 2016-06-30 2018-01-04 Koninklijke Philips N.V. Device, system and method for detecting an analyte in a body fluid sample containing a plurality of cells
WO2018011806A1 (en) 2016-07-11 2018-01-18 Yeda Research And Development Co. Ltd. Combination therapy to increase endogenous nitric oxide (no) synthesis
WO2018011805A9 (en) 2016-07-11 2018-05-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Systems and methods for growing cells in vitro
WO2018017673A1 (en) 2016-07-20 2018-01-25 Stcube, Inc. Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated pd-l1
WO2018015296A1 (en) 2016-07-20 2018-01-25 Vib Vzw Therapeutic agents for neurological and psychiatric disorders
WO2018020489A1 (en) 2016-07-24 2018-02-01 Yeda Research And Development Co. Ltd. Methods and kits for analyzing dna binding moieties attached to dna
WO2018033929A1 (en) 2016-08-18 2018-02-22 Yeda Research And Development Co. Ltd. Diagnostic and therapeutic uses of exosomes
WO2018037416A1 (en) 2016-08-25 2018-03-01 Yeda Research And Development Co. Ltd. Methods and compositions for treating autoimmune diseases
WO2018047154A1 (en) 2016-09-07 2018-03-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anti-nkp46 antibodies and therapeutic use of same
WO2018051347A1 (en) 2016-09-14 2018-03-22 Yeda Research And Development Co. Ltd. Crisp-seq, an integrated method for massively parallel single cell rna-seq and crispr pooled screens
WO2018085679A1 (en) 2016-11-04 2018-05-11 Stave James W Direct detection of microorganisms in patient samples by immunoassay
WO2018087759A1 (en) 2016-11-10 2018-05-17 Yeda Research And Development Co. Ltd. Phosphotriesterases for treating or preventing organophosphate exposure associated damage
WO2018096547A8 (en) 2016-11-28 2018-08-09 Yeda Research And Development Co. Ltd. Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
WO2018100574A1 (en) 2016-11-30 2018-06-07 Yeda Research And Development Co. Ltd. Methods of treating liver toxicity and disorders
EP3329905A1 (en) 2016-12-05 2018-06-06 Nuritas Limited Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin
EP3329930A1 (en) 2016-12-05 2018-06-06 Nuritas Limited Pharmaceuctical compositions
WO2018185760A1 (en) 2017-04-05 2018-10-11 Yeda Research And Development Co. Ltd. Ex-vivo culture system and methods of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615222A (en) * 1968-09-04 1971-10-26 New England Nuclear Corp Method and apparatus for measuring the amount of a component in a biological fluid
US3654090B1 (en) * 1968-09-24 1982-07-20

Also Published As

Publication number Publication date Type
ES396741A1 (en) 1975-05-16 application
GB1348935A (en) 1974-03-27 application
BE775187A (en) 1972-03-01 grant
FR2113733A5 (en) 1972-06-23 application
CA967464A1 (en) grant
FI54033C (en) 1978-09-11 grant
DK140268C (en) 1979-12-10 grant
DE2155658B2 (en) 1976-08-05 application
NL7016396A (en) 1972-05-15 application
DK140268B (en) 1979-07-16 grant
DE2155658C3 (en) 1978-09-14 grant
CA967464A (en) 1975-05-13 grant
DE2155658A1 (en) 1972-05-18 application
FI54033B (en) 1978-05-31 application
US3850752A (en) 1974-11-26 grant
BE775187A2 (en) grant

Similar Documents

Publication Publication Date Title
NL7501215A (en) Method for the detection and determination of an antigen or antibody.
NL162209C (en) A method for the detection of allergens directed against reagin-immunoglobulins, as well as apparatus and reagents for carrying out this method.
BE777790A (en) Apparaten voor het van ledigen kegelvormige tremels.
NL156819B (en) Method and device for the analysis of blood samples.
NL149466B (en) A process for the preparation of a refining agent for oily substances.
NL164861B (en) Process for the preparation of an amino penicillin.
NL166341C (en) Device for the cooling of an elongated body.
NL154363B (en) A process for the manufacture of a rectifier and rectifier obtained by this process.
NL157618B (en) Process for the preparation of tetrafluoroethylene copolymers in an aqueous medium.
NL143918B (en) A process for the preparation of a composition, shaped composition and method for the preparation of a n- (dihalophenyl) barnsteenzuurimidederivaat.
NL7510608A (en) Method and device for inspecting pipes.
BE775481A (en) voor het maken van aftreksels capsule lichamen waarin Zulke capsule wordt gebruikt.
NL144280B (en) Process for the preparation of an analgesic.
NL159294B (en) A method for the introduction of interference substances in semiconductor materials.
DE2151114B2 (en) Vehicle for inspecting pipelines
NL166871C (en) Improvement of the method for arc welding.
NL140339B (en) Improvement of a method for the examination of material samples, and improvement of a device for carrying out this method.
NL139548B (en) Process for the preparation of stabilized polyamides.
NL149007B (en) Method for the testing of concrete.
NL145048B (en) Method for the production of test strips for the detection of substances present in body fluids, as well as the thus prepared test strips.
NL139913B (en) Method for the stretching of polyamidefoelies.
NL166862C (en) Method for carrying out endothermic processes.
NL148953B (en) Method for the electrolytic hydrodimerized of alpha-beta-unsaturated nitriles.
NL164243C (en) Device for the packaging of goods.
BE751658A (en) Apparatus for the treatment of coils, and the like.

Legal Events

Date Code Title Description
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: ORGANON

V4 Lapsed because of reaching the maxim lifetime of a patent